WI0501074_Application_20211110

North Carolina Department of Environmental Quality — Division of Water Resources
APPLICATION FOR PERMIT TO CONSTRUCT AND/OR USE A WELL(S) FOR INJECTION
Groundwater Remediation (15A NCAC 02C .0225)
Do not use this form for UIC wells Permitted by Rule (ref. 15A NCAC 02C .0217)
Permit Number (to be completed by DWR for new projects): WI0501074
I. APPLICATION INFORMATION
1. Project is: [ ] New [X ] Modification [ ] Renewal without modification [ ] Renewal with modification
2. If this application is being submitted for Renewal and/or Modification to an existing permit, provide:
Existing permit number WI0501074 Issued Date: 7-2-2021 & Expiration Date: 5-31-2026
For all Renewals, attach an updated site map and status report including monitoring results of all injection activities
to date.
For Renewal without modification only, fill out sections I & II only, sign the certification on the last page of this form,
and obtain the property owner's signature to indicate consent (f the applicant is not the owner).
II. WELL OWNER(S)/PERMIT APPLICANT (generally the responsible party)
1. Name(s): Schlage Lock Company LLC
2. Signing Official's Name*: Russell E. Eiler Title: Director, Global EHS Compliance, Schlage Lock Company LLC
* Signing Official must be in accordance with instructions in Part XII.
3. Mailing address of Permittee/Applicant: 11819 N. Pennsylvania St.
City: Carmel
State: IN Zip: 46032
4. Telephone number: 1-317-810-3874 Email: [e-mail]
5. Status (choose one): Individual X Business/Org. Federal State County Municipality
III. PROPERTY OWNER(S) (if different than well owners)
1. Name(s): Agrede, LLC (Greg Hodges)
2. Mailing address: 400 English Rd
City: Rocky Mount
State: NC Zip: 27804
3. Telephone number: 252-985-1070 Email: N/A
IV. PROJECT CONTACT — (generally the environmental/engineering consultant).
1. Name: Mike Burcham Title: Project Engineer
2. Company: Geosyntec Consultants of NC, P.C.
3. Address: 2501 Blue Ridge Rd, Ste 430
4. City: Raleigh State: NC Zip: 27607
5. Telephone number: [phone] Email: mburcham(ageosyntec.com
Groundwater Remediation Application Rev. 2-17-2020 Page 1 of 9

V. FACILITY INFORMATION
1. Facility name:
Former Schlage Lock Plant Phone No. (if available):
2. Physical address: 213 Red Iron Road
City: Rocky Mount County: Nash Zip: 27804
3. Geographic Coordinates: Latitude: 36° 01' 25"
Longitude: 77°46' 00"
Reference Datum: World Geodetic System, 1984 (WGS84) Accuracy: N/A
Method of Collection (i.e., Google Earth, GPS, etc.): Google Maps
4. Brief description of business:
VI. INCIDENT DESCRIPTION
1. Source and date of contamination: PCE impacts first identified on site in 1986. RCRA Facility Assessment
Report identified multiple solid waste management units and areas of concern. They were generally associated
with historical industrial activities (degreaser), chlorinate solvent storage (PCE transfer vault), and drum storage.
2. List all contaminants present in soils or groundwater at the site (contaminants may be listed in groups, e.g., gasoline,
diesel, jet fuel, fuel oil, chlorinated ethenes, chlorinated ethanes, metals, pesticides/herbicides, etc):
Chlorinated volatile organic compounds
3. Has LNAPL or DNAPL ever been observed at the site (even if outside the injection zone)?
[X] YesIf yes, list maximum measured separate phase thickness: not measured
feet
[ ] No If no, list maximum concentration of total VOCs observed at site: ppb
4. Agency managing the contamination incident:
[ ] UST Section [ ] Superfund Section (including REC Program and DSCA sites)
[ ] DWR Aquifer Protection Section [ ] Solid Waste Section
[X] Hazardous Waste Section [ ] Other:
5. Incident manager's name: Rob McDaniel Phone No.: 919-707-8215
6. Incident number or other incident mgmt. agency tracking number: NCD 065 300 519
Groundwater Remediation Application Rev. 2-17-2020 Page 2 of 9

VII. PERMITS
List all applicable permits or construction approvals issued for the facility or incident:
1. Previous or other UIC permits issued by DWR (e.g., NOIs) WI0500984 for potable drip water for thermal
remediation electrodes
2. Other Non -Discharge or NPDES permit issued by DWR: NPDES NC0079227
3. County or DEH subsurface wastewater disposal permits:
4. Hazardous waste management or other environmental permits required by state or federal law:
Groundwater Remediation Application Rev. 2-17-2020 Page 3 of 9

VIII. INJECTION SUMMARY
1. List all proposed injectants/additives.
NOTE: Only injectants approved by the epidemiology section of the NC Division of Public Health, Department of
Health and Human Services can be injected. Approved injectants can be found online at
http: //deq.nc.gov/about/divisions/water-re sources/water-resources-permits/wastewater-branch/ground-water-
protection/ground-water-approved-injectants. All other substances must be reviewed by the DHHS prior to use.
Contact the UIC Program for more info if you wish to get approval for a different additive. However, please note
it may take 3 months or longer. If no injectants are to be used use N/A.
Injectant: ABC Total Amt. to be injected (gal)/event: 11,000
Injectant: ABC+ Total Amt. to be injected (gal)/event: 2,700 (from 3,000)
Injectant: KB-1/KB-1 Plus Total Amt. to be injected (L)/event: 465 total (180 KB-1 /285
KB-1 Plus) (from 325 total)
Injectant: Buffering - Magnesium Hydroxide Total Amt. to be injected (lb)/event: 4,500 (from 5,400)
Injectant: Buffering — Sodium Bicarbonate Total Amt. to be injected (lb)/event: 51,000 (from 130,000)
Injectant: Sodium Sulfite Total Amt. to be injected (lb)/event: 150 (from 287)
Injectant: KB-1 Primer Total Amt. to be injected (lb)/event: 900 (from 1,200)
Injectant: Dechlorinator Total Amt. to be injected (gal)/event: 0 gal (from 1.5)
Total Amt. to be injected (gal/event):
(reduced from 550,000 gal total)
325,000 2a1 of diluted ABC/ABC+ and anaerobic chase water
No. of separate injection events: 1 Total Amt. to be injected (gal): 325,000
Source of Water (if applicable): On -site fire hydrant(s)
2. Estimated Injection rate per well: 4-8 GPM
3. Estimated Injection pressure: 5-100 pounds/square inch (PSI)
4. Temperature at point of injection: ambient °F
5. Injection will be via:
Existing well(s)- Total No.: N/A ; Well Type (DPT, Permanent, etc.): N/A
Proposed well(s)- Total No.: 102 (from 89) ; Well Type (DPT, Permanent, etc.): Temporary DPT
6. NC Certified Well Drilling Contractor's Name (if known): TBD
NC Well Contractor Certification No.: TBD
7. Date to be constructed if proposed: As soon as possible (may be less than 2 months post -approval)
(attach well construction records [GW-1s] for existing injection wells)
8. Screened interval/Injection interval of injection wells:
Depth from 12 to 50 feet below land surface (BLS) (if multiple intervals, indicate
shallowest to deepest depth)
9. Well casing (leave blank if Geoprobes®):
Type (PVC, stainless steel, other):
Casing depth: to ft. BLS
Type (PVC, stainless steel, other):
Groundwater Remediation Application Rev. 2-17-2020
Page 4 of 9

Casing depth:
to ft. BLS
10. Grout (leave blank if Geoprobes):
Type (cement, bentonite, other):
Grout depth: to ft. BLS
Type (cement, bentonite, other):
Grout depth: to ft. BLS
IX. ATTACHMENTS — provide the following information in separate attachments. The attachments should be clearly
identified and presented in the order below to expedite review of the permit application package.
1. INJECTION ZONE — Per 15A NCAC 02C .0225(f)(3), specify the horizontal and vertical portion of the subsurface within
which the proposed injection activity will take place and beyond which no violations of groundwater quality standards shall
result from the injection as determined by an approved monitoring plan. The determination shall be based on the hydraulic
properties of the specified zone. Provide any supporting documentation in a separate attachment.
2. HYDROGEOLOGIC EVALUATION — Per 15A NCAC 02C .0225(f)(4), provide a hydrogeologic evaluation of the injection
zone that includes all of the following:
(A) Regional and local geology and hydrology;
(B) Changes in lithology underlying the facility;
(C) Depth to bedrock;
(D) Depth to the mean seasonal high water table;
(E) Hydraulic conductivity, transmissivity, and storativity, of the injection zone based on tests of site -specific material,
including a description of the test(s) used to determine these parameters;
(F) Rate and direction of groundwater flow as determined by predictive calculations or computer modeling;
(G) Lithostratigraphic and hydrostratigraphic logs of any existing test and injection wells; and
(H) For systems re -injecting treated on -site contaminated groundwater only- evaluation of infiltration galleries or
injection wells.
3. INJECTANT INFORMATION — Per 15A NCAC 02C .0225(0(6). provide information on each injectant as indicated below:
(A) MSDS, concentration at the point of injection, and percentage if present in a mixture with other injectants;
(B) The source of fluids used to dilute, carry, or otherwise distribute the injectant throughout the injection zone. If any
well within the area of review of the injection facility is to be used as the fluid source, then the following information
shall be submitted: location/ID number, depth of source, formation, rock/sediment type, and a chemical analysis
of the water from the source well, including analyses for all contaminants suspected or historically recognized in
soil or groundwater on the site;
(C) A description of the rationale for selecting the injectants and concentrations proposed for injection, including an
explanation or calculations of how the proposed injectant volumes and concentrations were determined;
(D) A description of the reactions between the injectants and the contaminants present including specific breakdown
products or intermediate compounds that may be formed by the injection;
(E) A summary of results if modeling or testing was performed to investigate the injectant's potential or susceptibility
for biological, chemical, or physical change in the subsurface; and
(F) An evaluation concerning the development of byproducts of the injection process, including increases in the
concentrations of naturally occurring substances. Such an evaluation shall include the identification of the specific
byproducts of the injection process, projected concentrations of byproducts, and areas of migration as determined
through modeling or other predictive calculations.
Groundwater Remediation Application Rev. 2-17-2020 Page 5 of 9

4. INJECTION PROCEDURE — Per 15A NCAC 02C .0225(0(7). submit a table with a detailed description of the proposed
injection procedure that includes the following:
(A) The proposed average and maximum daily rate and quantity of injectant;
(B) The average maximum injection pressure expressed in units of pounds per square inch (psi); and
(C) The total or estimated total volume to be injected.
5. FRACTURING PLAN (if applicable) — Per 15A NCAC 02C .0225(f)(9), submit a detailed description of the fracturing plan
that includes the following:
(A) Material Safety Data Sheets of fracturing media including information on any proppants used;
(B) a map of fracturing well locations relative to the known extent of groundwater contamination plus all buildings,
wells, septic systems, underground storage tanks, and underground utilities located within the Area of Review;
(C) a demonstration that buildings, wells, septic systems, underground storage tanks, and underground utilities will not
be adversely affected by the fracturing process;
(D) injection rate and volume;
(E) orientation of bedding planes, joints, and fracture sets of the fracture zone;
(F) performance monitoring plan for determining the fracture well radius of influence; and
(G) if conducted, the results of geophysical testing or pilot test of fracture behavior conducted in an uncontaminated
area of the site.
6. WELL CONSTRUCTION DETAILS — Per 15A NCAC 02C .0225(f)(10), submit the following information in tabular or
schematic form as appropriate for each item:
(A) number and depth of injection wells;
(B) number and depth of borings if using multi -level or "nested" well systems;
(C) indication whether the injection wells are existing or proposed;
(D) depth and type of casing;
(E) depth and type of screen material;
(F) depth and type of grout;
(G) indication whether the injection wells are permanent or temporary "direct push" points; and
(H) plans and specifications of the surface and subsurface construction details.
7. MONITORING PLAN — Per 15A NCAC 02C .0225(f)(11). submit a monitoring plan that includes the following:
(A) target contaminants plus secondary or intermediate contaminants that may result from the injection;
(B) other parameters that may serve to indicate the progress of the intended reactions;
(C) a list of existing and proposed monitoring wells to be used; and
(D) a sampling schedule to monitor the proposed injection.
Monitoring wells shall be of sufficient quantity and location to detect any movement of injection fluids, injection process byproducts, or
formation fluids outside the injection zone. The monitoring schedule shall be consistent with the proposed injection schedule, pace of
the anticipated reactions, and rate of transport of the injectants and contaminants.
8. WELL DATA TABULATION — Per 15A NCAC 02C .0225(0(12). provide a tabulation of data on all existing or abandoned
wells within the area of review of the injection well(s) that penetrate the proposed injection zone, including monitoring
wells and wells proposed for use as injection wells. Such data shall include a description of each well's type, depth, and
record of construction or abandonment.
9. MAPS AND CROSS -SECTIONS — Per 15A NCAC 02C .0225(f)(13), provide scaled, site -specific site plans or maps
depicting the location, orientation, and relationship of facility components including the following:
(A) area map based on the most recent USGS 7.5' topographic map of the area, at a scale of 1:24,000 and showing the
location of the proposed injection site;
(B) topographic contour intervals showing all facility related structures, property boundaries, streams, springs, lakes,
ponds, and other surface drainage features;
(C) all existing or abandoned wells within the area of review of the wells listed in the well data tabulation that penetrate
the proposed injection zone;
(D) potentiometric surface map(s) that show the direction of groundwater movement, existing and proposed wells;
(E) contaminant plume map(s) with isoconcentration lines that show the horizontal extent of the contaminant plume in
soil and groundwater, and existing and proposed wells;
Groundwater Remediation Application Rev. 2-17-2020 Page 6 of 9

(F) cross-section(s) to the known or projected depth of contamination that show the horizontal and vertical extent of
the contaminant plume in soil and groundwater, major changes in lithology, and existing and proposed wells; and
(G) any existing sources of potential or known groundwater contamination, including waste storage, treatment, or
disposal systems within the area of review of the injection well or well system.
X. UIC SYSTEMS RE -INJECTING TREATED ON -SITE CONTAMINATED GROUNDWATER ONLY
1. FEES — Per 15A NCAC 02C .0225(m), submit/attach fees for new permits or modifications (refer to fee schedule
at https://deq.nc.gov/about/divisions/water-resources/water-resources-permits/wastewater-branch/ground-water-
protection/non-discharge-groundwater-remediation
2. SOILS EVALUATION - Per 15A NCAC 02C .0225(0(2), for systems with proposed discharge within seven feet
of land surface and above the seasonal high water table, a soil evaluation of the disposal site shall be provided to the
Division by the applicant. If required by G.S. 89F, a soil scientist shall submit this evaluation. This evaluation shall be
presented in a report that includes the following information:
(A) Field description of soil profile. Based on examinations of excavation pits or auger borings, the following
parameters shall be described by individual horizons to a depth of seven feet below land surface or to bedrock:
thickness of the horizon; texture; color and other diagnostic features; structure; internal drainage; depth, thickness,
and type of restrictive horizons; pH; cation exchange capacity; and presence or absence of evidence of any seasonal
high water table. Applicants shall dig pits when necessary for evaluation of the soils at the site.
(B) Recommendations concerning annual and instantaneous loading rates of liquids, solids, other wastewater
constituents and amendments. Annual hydraulic loading rates shall be based on in -situ measurement of saturated
hydraulic conductivity in the most restrictive horizon.
3. ENGINEERING PLANNING DOCUMENTS — Per 15A NCAC 02C .0225(0(8), the following documents shall
be provided to the Division by the applicant (Note: if required by G.S. 89C, a professional engineer shall prepare
these documents):
(A) engineering plans for the entire system, including treatment, storage, application, and disposal facilities and
equipment, except those previously permitted unless they are directly tied into the new units or are critical to the
understanding of the complete process;
(B) specifications describing materials to be used, methods of construction, and means for ensuring quality and integrity
of the entire groundwater remediation system;
(C) plans that include construction details of recovery, injection, and monitoring wells and infiltration galleries;
(D) operating plans that include:
(i) the operating schedule including any periodic shut -down times;
(ii) required maintenance activities for all structural and mechanical elements;
(iii) a list of all consumable and waste materials with their intended source and disposal locations;
(iv) restrictions on access to the site and equipment;
(v) provisions to ensure the quality of the treated effluent and hydraulic control of the system at all times when
any portion of the system ceases to function, such as standby power capability, complete system -off status,
or duplicity of system components; and
(E) Completed, signed, and sealed Professional Engineer's Certification for new permit applications (form attached).
Groundwater Remediation Application Rev. 2-17-2020 Page 7 of 9

XII. CERTIFICATION (to be signed as required below or by that person's authorized agent*)
NCAC 15A 02C .021 1(e) requires that all permit applications shall be signed as follows:
1. for a corporation: by a responsible corporate officer
2. for a partnership or sole proprietorship: by a general partner or the proprietor, respectively
3. for a municipality or a state, federal, or other public agency: by either a principal executive officer or
ranking publicly elected official
4. for all others: by the well owner.
*If an authorized agent is signing on behalf' of the applicant, then supply a letter signed by the applicant
that names and authorizes their agent.
"l hereby certify under penalty of law that l have personally examined and am familiar with the information
submitted in this document and all attachments therein, and that, based on my ins/llir.y of those indii'iduals
immediately responsible for obtaining said information, / believe that the information is true, accurate. and
complete. 1 can aware that there are penalties, including the possibility of fines and imprisonment, for submitting
false information. / agree to construct, operate, maintain, repair, and if applicable, abandon the Injection well(s)
and all related appurtenances in accordance with the approved specifications and conditions of the Permit."
Typed or Printed/Nan) and Tij e: J) RAell E. Eller, Director, Global EHS Compliance
Signature:
Date: November 04, 2021
XIII. CONSENT OF PROPERTY OWNER (if the property is not owned by the permit applicant)
"Owner" means any person who holds the fee or other property rights in the well being constructed. A well is real
property and its construction on land shall be deemed to vest ownership in the land owner, in the absence of contra►y
agreement in writing.
"As owner of the property on which the injection well(s) are to be constructed and operated, / hereby consent to
allow the applicant to construct each injection well as outlined in this application and agree that it shall be the
responsibility of the applicant to ensure that the injection well(s) conform to the Well Construction Standards
(I SA NCAC 02C .0200)."
Typed or Printed Name and Title: (De n ��r? �. C�E"
Signature:
Date: / /// 1/a")_2
Submit TWO hard copies of the completed application package with an electronic version in CD or USB Flash
Drive to:
DIVISION OF WATER RESOURCES — UIC PROGRAM
1636 MAIL SERVICE CENTER
RALEIGH, NORTH CAROLINA 27699-1636
TELEPHONE NUMBER: [phone]
Groundwater Re►nediation Application Rev. 2-17-2020 Page $ of 9

Professional Engineer's Certification (for new permit application for UIC systems re -injecting treated on -site
contaminated groundwater on :
Permit No.: NOT APPLICABLE
Typed or Printed Name of Professional Engineer:
License Number:
Name of Engineering Firm (if applicable):
Mailing Address:
City: State: Zip:
Office Number: ( ) Mobile Number: ( )
Email Address:
attest that this application for
has been reviewed by me and is accurate and complete to the best of my knowledge. I further attest that to the best
of my knowledge the proposed design has been prepared in accordance with the applicable regulations. Although
certain portions of this submittal package may have been developed by other professionals, inclusion of these materials
under my signature and seal signifies that I have reviewed this material and have judged it to be consistent with the
proposed design.
North Carolina Professional Engineer's Seal, Signature, and Date:
Groundwater Remediation Application Rev. 2-17-2020 Page 9 of 9

1. INJECTION ZONE — Per 15A NCAC 02C .0225(f)(3), specify the horizontal and vertical portion
of the subsurface within which the proposed injection activity will take place and beyond which no
violations of groundwater quality standards shall result from the injection as determined by an
approved monitoring plan. The determination shall be based on the hydraulic properties of the
specified zone. Provide any supporting documentation in a separate attachment.
Modification description: All locations where Middle and Lower Aquifers will be treated were
modified such that they will be completed using separate boreholes (i.e., one borehole for Middle
Aquifer and a second borehole for Lower Aquifer). This increased the number of separate
injection locations from 89 to 102. This modification did not result in appreciable changes to
injection locations and the overall injection footprint.
The general injection areas are provided on Figure 5, attached (Geosyntec, 2021b) and the
specific injection locations are provided on Figures 6 through 7, attached (Geosyntec, 2021b).
These figures do not provide vertical extents of the injection locations. Tables 3 and 4, attached
(Geosyntec, 2021b) provide proposed injection intervals for each injection location.

Table 3. Injection Location Coordinates and Treatment Intervals
Allegion Rocky Mount
Rocky Mount, North Carolina
Geosyntec °
consultants
Geosyntec Consultants of NC, P.C.
Injection Area
DPT
Injection
Location ID
Target Aquifer(s)
ZVI?
Treatment
Interval
(ft BLS)
Monitoring Well(s)
Used for Design
Primary PCE
Concentration(s)
(µg/L)
Notes
High Concentration Injection Locations
High
Concentration
Area 1
(HC1)
HC1-01
Middle / Lower
18 to 32 /
40 to 50
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-02
Middle / Lower
18 to 32 /
38 to 50
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-03
Middle / Lower
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-04
Middle / Lower
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-05
Middle / Lower
14 to 36 /
40 to 50
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-06
Middle / Lower
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
High
Concentration
Area2
(HC2)
HC2-01
Middle
✓
16 to 32
MW-75S
103,000
HC2-02
Middle
✓
MW-75S
103,000
HC2-03
Middle
✓
MW-75S
103,000
HC2-04
Middle
✓
MW-75S
103,000
HC2-05
Middle
✓
MW-75S
103,000
HC2-06
Middle
✓
MW-75S
103,000
HC2-07
Middle
✓
MW-75S
103,000
HC2-08
Middle
✓
MW-75S
103,000
HC2-09
Middle
✓
MW-75S
103,000
HC2-10
Middle
✓
MW-75S
103,000
HC2-11
Middle
✓
MW-75S
103,000
HC2-12
Middle
19 to 31
MW-75S
103,000
HC2-13
Middle
MW-75S
103,000
HC2-14
Middle
MW-75S
103,000
HC2-15
Middle
MW-75S
103,000
HC2-16
Middle
22 to 36
MW-22
6,550
HC2-17
Middle
MW-22
6,550
HC2-18
Middle
MW-22
6,550
HC2-19
Middle
MW-75S
103,000
HC2-20
Middle
21 to 33
MW-75S
103,000
HC2-21
Middle
MW-75S
103,000
HC2-22
Middle
MW-75S
103,000
HC2-23
Middle
MW-76S
5,630
HC2-24
Middle
MW-76S
5,630
HC2-25
Middle
19 to 31
MW-76S
5,630
HC2-26
Middle
MW-75S
103,000
HC2-27
Middle
MW-75S
103,000
HC2-28
Middle
MW-75S
103,000
HC2-29
Middle
MW-75S
103,000
HC2-30
Middle
MW-75S
103,000
High
Concentration
Area 3
(HC3)
HC3-01
Middle
✓
16 to 30
MW-78S
22,800
HC3-01
Lower
34 to 50
MW-78D
8,900
Lower injection interval at HC3-01 will not receive ZVI
HC3-02
Middle
.716
to 30
MW-78S
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
Lower
34 to 50
MW-78D
HC3-03
Middle / Lower
✓
16 to 30 / 34
to 50
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-04
Middle / Lower
✓
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-05
Middle
18 to 30
MW-78S
22,800
HC3-06
Middle
MW 78S
22,800
HC3-07
Middle
18 to 30
MW-78S
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
Lower
✓
34 to 50
MW-78D
HC3-08
Middle / Lower
18 to 30 / 34
to 50
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-09
Middle / Lower
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-10
Middle / Lower
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-11
Middle
17 to 29
MW-78S
22,800
HC3-12
Middle
MW-78S
22,800
HC3-13
Middle
MW-78S
22,800
HC3-14
Middle
MW-58S
5,400
HC3-15
Middle
MW-58S
5,400
High
Concentration
Area 4
(HC4)
HC4-01
Lower
26 to 46
MW-30
3,260
HC4-02
Lower
MW-30
3,260
HC4-03
Lower
MW-30
3,260
Downgradient Injection Locations
Downgradient
Area 1
(DGl)
DG1-01
Middle
12 to 22
MW-37S
474
DG1-02
Middle
MW-37S
474
DG1-03
Middle
12 to 22
MW-37S
474
DG1-04
Middle
MW-37S
474
DG1-05
Middle
12 to 24
MW-37S
474
DG1-06
Middle / Lower
12 to 22 /
25 to 41
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-07
Middle / Lower
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-08
Middle / Lower
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-09
Middle / Lower
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-10
Middle
12 to 22
MW-37S
474
DG1-11
Middle
MW-37S
474
DG1-12
Middle
MW-37S
474
DG1-13
Middle
MW-37S
474
DG1-14
Middle
MW-37S
474
Downgradient
Area 2
)
DG2-01
Lower
35 to 45
MW-74D
86.6
DG2-02
Lower
MW-74D
86.6
DG2-03
Lower
MW-74D
86.6
DG2-04
Lower
MW-74D
86.6
Downgradient
Area 3
(DG3)
DG3-01
Lower
38 to 50
MW-41DDR
377
DG3-02
Lower
MW-41DDR
377
DG3-03
Lower
MW-41DDR
377
DG3-04
Lower
MW-41DDR
377
DG3-05
Lower
MW-41DDR
377
DG3-06
Lower
MW-41DDR
377
DG3-07
Lower
MW-41DDR
377
DG3-08
Lower
MW-41DDR
377
DG3-09
Lower
MW-70D
172
DG3-10
Lower
40 to 50
MW-70D
172
DG3-11
Lower
MW-70D
172
DG3-12
Lower
MW-70D
172
Notes:
1. ft BLS indicates feet below land surface.
2. DPT indicates direct push technology.
3. PCE indicates tetrachloroethene.
4. µg/L indicates micrograms per liter.
5. ✓ indicates zero-valent iron (ZVI) is included at the location. No fill indicates ZVI will not be included.
6. Primary PCE Concentration(s) provides the most recent PCE sampling result (as of February 2021) for the monitoring well(s) used for design.
7. All locations will be confirmed in the field, based on nearby monitoring wells.
2021 Bioremediation Interim Measures Workplan Page 1 of 1

Table 4. Injection Location Volumes
Allegion Rocky Mount
Rocky Mount, North Carolina
Geasyntec°
consultants
IP : ("un%Pl[nnb nl NC. PC
ABC+* Amendment Injection Locations (includes ZVI)
Per 2-ft Injection Interval
Per Injection Location
Target
Aquifer
Injection
Area
Injection Locations
Treatment
Interval
(ft BLS)
Injection
Interval
(ft BLS)
Target
ROI
(ft)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
High Concentration Area - 0.3 lb of Carbon Amendment per ft3 of Treatment Volume
Middle
Aquifer
HC2
HC2-01, HC2-02,
HC2-03, HC2-04,
HC2-05, HC2-06,
HC2-07, HC2-08,
HC2-09, HC2-10,
HC2-11
16 to 32
16
to
18
14
283
109
0.65
2.264
872
5.20
18
to
20
14
283
109
0.65
20
to
22
14
283
109
0.65
22
to
24
14
283
109
0.65
24
to
26
14
283
109
0.65
26
to
28
14
283
109
0.65
28
to
30
14
283
109
0.65
30
to
32
14
283
109
0.65
HC3
HC3-01, HC3-02,
HC3-03, HC3-04
16 to 30
16
to
18
14
284
108
0.65
1.988
756
4.55
18
to
20
14
284
108
0.65
20
to
22
14
284
108
0.65
22
to
24
14
284
108
0.65
24
to
26
14
284
108
0.65
26
to
28
14
284
108
0.65
28
to
30
14
284
108
0.65
Lower
Aquifer
HC3
HC3-03, HC3-04,
HC3-07
34 to 50
34
to
36
14
288
105
0.65
2.304
840
5.20
36
to
38
14
288
105
0.65
38
to
40
14
288
105
0.65
40
to
42
14
288
105
0.65
42
to
44
14
288
105
0.65
44
to
46
14
288
105
0.65
46
to
48
14
288
105
0.65
48
to
50
14
288
105
0.65
ABC® Amendment Injection Location (no ZVI) OM
Per 2-ft Injection Interval
Per Injection Location
Target
Aquifer
Injection
Area
Injection Locations
Treatment
Interval
(ft BLS)
Injection
Interval
(ft BLS)
Target
ROI
(ft)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
High Concentration 0.3 lb of Carbon Amendment per fe of Treatment Volume
Middle
Aquifer
HCl
HC1-01,HC1-02,
HC1-03,HC1-04
188032
18
to
20
14
379
83
0.65
2,653
581
4.55
20
to
22
14
379
83
0.65
22
to
24
14
379
83
0.65
24
to
26
14
379
83
0.65
26
to
28
14
379
83
0.65
28
to
30
14
379
83
0.65
30
to
32
14
379
83
0.65
HC1
HC1-05,HC1-06
14to36
14
to
16
14
382
79
0.65
4.202
869
7.15
16
to
18
14
382
79
0.65
18
to
20
14
382
79
0.65
20
to
22
14
382
79
0.65
22
to
24
14
382
79
0.65
24
to
26
14
382
79
0.65
26
to
28
14
382
79
0.65
28
to
30
14
382
79
0.65
30
to
32
14
382
79
0.65
32
to
34
14
382
79
0.65
34
to
36
14
382
79
0.65
HC2
HC2-12, HC2-13,
HC2-14, HC2-15,
HC2-25, HC2-26,
HC2-27, HC2-28,
HC2-29, HC2-30
19 to 31
19
to
21
14
377
84
0.65
2.262
504
3.90
21
to
23
14
377
84
0.65
23
to
25
14
377
84
0.65
25
to
27
14
377
84
0.65
27
to
29
14
377
84
0.65
29
to
31
14
377
84
0.65
HC2
HC2-16, HC2-17,
HC2-18, HC2-19
22 to 36
22
to
24
14
379
83
0.65
2,653
581
4.55
24
to
26
14
379
83
0.65
26
to
28
14
379
83
0.65
28
to
30
14
379
83
0.65
30
to
32
14
379
83
0.65
32
to
34
14
379
83
0.65
34
to
36
14
379
83
0.65
HC2
HC2-20, HC2-21,
HC2-22, HC2-23,
HC-24
21 to 33
21
to
23
14
380
81
0.65
2,280
486
3.90
23
to
25
14
380
81
0.65
25
to
27
14
380
81
0.65
27
to
29
14
380
81
0.65
29
to
31
14
380
81
0.65
31
to
33
14
380
81
0.65
HC3
HC3-05, HC3-06,
HC3-07, HC3-08
HC3-09, HC3-10
18 to 30
18
to
20
14
378
83
0.65
2,268
498
3.90
20
to
22
14
378
83
0.65
22
to
24
14
378
83
0.65
24
to
26
14
378
83
0.65
26
to
28
14
378
83
0.65
28
to
30
14
378
83
0.65
HC3
HC3-11, HC3-12,
HC3-13, HC3-14,
HC3-15
17 to 29
17
to
19
14
380
81
0.65
2,280
486
3.90
19
to
21
14
380
81
0.65
21
to
23
14
380
81
0.65
23
to
25
14
380
81
0.65
25
to
27
14
380
81
0.65
27
to
29
14
380
81
0.65
2021 Bioremediation Interim Measures Workplan Page 1 of 2

Table 4. Injection Location Volumes
Allegion Rocky Mount
Rocky Mount, North Carolina
Geasyntec°
consultants
1,
Ic+� ConsRltnnb nl NC. PC
ABC® Amendment Injection Location (no ZVI)
Per 2-ft Injection Interval
Per Injection Location
Target
Aquifer
Injection
Area
Injection Locations
Treatment
Interval
(ft BLS)
Injection
Interval
(ft BLS)
Target
ROI
(ft)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
High Concentration 0.3 Ib of Carbon Amendment per ftS of Treatment Volume
Lower
Aquifer
HC1
HC1-01,HC1-O5,
HC1-06
40 to 50
40
to
42
14
387
74
0.65
1,935
370
3.25
42
to
44
14
387
74
0.65
44
to
46
14
387
74
0.65
46
to
48
14
387
74
0.65
48
to
50
14
387
74
0.65
HCl
HC1-02,HC1-03,
HC1-04
38to50
38
to
40
14
378
83
0.65
2,268
498
3.90
40
to
42
14
378
83
0.65
42
to
44
14
378
83
0.65
44
to
46
14
378
83
0.65
46
to
48
14
378
83
0.65
48
to
50
14
378
83
0.65
HC3
HC3-01, HC3-02,40
HC3-08 HC3-09,
HC3-10
34 to 50
34
to
36
14
380
81
0.65
3.040
648
5.20
36
to
38
14
380
81
0.65
38
to
40
14
380
81
0.65
to
42
14
380
81
0.65
42
to
44
14
380
81
0.65
44
to
46
14
380
81
0.65
46
to
48
14
380
81
0.65
48
to
50
14
380
81
0.65
HC4
HC4-01, HC4-02,
HC4-03
26 to 46
26
to
28
14
380
81
0.65
3,800
810
6.50
28
to
30
14
380
81
0.65
30
to
32
14
380
81
0.65
32
to
34
14
380
81
0.65
34
to
36
14
380
81
0.65
36
to
38
14
380
81
0.65
38
to
40
14
380
81
0.65
40
to
42
14
380
81
0.65
42
to
44
14
380
81
0.65
44
to
46
14
380
81
0.65
Downgradient Area - 0.30 Ib of Carbon Amendment per ft3 of Treatment Volume
Middle
Aquifer
DG1
DG1-05
12 to 24
12
to
14
14
467
110
0.80
2.802
660
4.80
14
to
16
14
467
110
0.80
16
to
18
14
467
110
0.80
18
to
20
14
467
110
0.80
20
to
22
14
467
110
0.80
22
to
24
14
467
110
0.80
DG1
DG1-01, DG1-02,
DG1-03, DG1-04,
DG1-06, DG1-07,
DG1-08, DG1-09,
DG1-10, DG1-11,
DG1-12, DG1-13,
DG1-14
12 to 22
12
to
14
14
465
112
0.80
2.325
560
4.00
14
to
16
14
465
112
0.80
16
to
18
14
465
112
0.80
18
to
20
14
465
112
0.80
20
to
22
14
465
112
0.80
Lower
Aquifer
DG1
DG1-06, DG1-07,
DG1-08, DG1-09
25 to 41
25
to
27
14
475
101
0.80
3.800
808
6.40
27
to
29
14
475
101
0.80
29
to
31
14
475
101
0.80
31
to
33
14
475
101
0.80
33
to
35
14
475
101
0.80
35
to
37
14
475
101
0.80
37
to
39
14
475
101
0.80
39
to
41
14
475
101
0.80
DG235
DG2-01, DG2-02,
DG2-03, DG2-04
to 45
35
to
37
14
470
106
0.80
2,350
530
4.00
37
to
39
14
470
106
0.80
39
to
41
14
470
106
0.80
41
to
43
14
470
106
0.80
43
to
45
14
470
106
0.80
DG3
DG3-01, DG3-02,
DG3-03, DG3-04,
DG3-05, DG3-06,
DG3-07, DG3-08,
DG3-09
38 to 50
38
to
40
14
474
102
0.80
'.844
612
4.80
40
to
42
14
474
102
0.80
42
to
44
14
474
102
0.80
44
to
46
14
474
102
0.80
46
to
48
14
474
102
0.80
48
to
50
14
474
102
0.80
DG3
DG3-10, DG3-11,
DG3-12
40 to 50
40
to
42
14
467
110
0.80
2,335
550
4.00
42
to
44
14
467
110
0.80
44
to
46
14
467
110
0.80
46
to
48
14
467
110
0.80
48
to
50
14
467
110
0.80
Notes:
1. ft BLS indicates feet below land surface.
2. gal indicates gallons.
3. ZVI indicates zero-valent iron.
4. Ib indicates pound.
5. ft' indicates cubic foot.
6. KB-1 Volume refs to the volume ofbioaugmentation culture required. See Work Plan for details on the selection of KB-1 versus KB-1 Plus by location.
2021 Bioremediation Interim Measures Workplan Page 2 of 2

3. INJECTANT INFORMATION— Per 15A NCAC 02C .0225(0(6). provide information on each injectant
as indicated below:
(A) MSDS, concentration at the point of injection, and percentage if present in a mixture with
other injectants;
(B) The source of fluids used to dilute, carry, or otherwise distribute the injectant throughout the
injection zone. If any well within the area of review of the injection facility is to be used as
the fluid source, then the following information shall be submitted: location/ID number,
depth of source, formation, rock/sediment type, and a chemical analysis of the water from the
source well, including analyses for all contaminants suspected or historically recognized in
soil or groundwater on the site;
(C) A description of the rationale for selecting the injectants and concentrations proposed for
injection, including an explanation or calculations of how the proposed injectant volumes and
concentrations were determined;
(D) A description of the reactions between the injectants and the contaminants present including
specific breakdown products or intermediate compounds that may be formed by the
injection;
(E) A summary of results if modeling or testing was performed to investigate the injectant's
potential or susceptibility for biological, chemical, or physical change in the subsurface; and
(F) An evaluation concerning the development of byproducts of the injection process, including
increases in the concentrations of naturally occurring substances. Such an evaluation shall
include the identification of the specific byproducts of the injection process, projected
concentrations of byproducts, and areas of migration as determined through modeling or
other predictive calculations.
Modification description: Modifications to the injectants are summarized below.
• The concentration of ABC+/ABC at the point of injection has been modified as shown below:
Treatment
Area
Aquifer
Carbon
Amendment
Diluted
Carbon
Amendment
Concentration
(lb/gal)
ZVI
ZVI
Concentration
(lb/gal)
High
Concentration
Middle
ABC+
0.55
ZVI
0.55
Lower
0.55
ZVI
0.55
Middle
ABC
0.41
--
--
Lower
0.41
--
--
Downgradient
Middle
ABC
0.41
--
--
Lower
0.41
--
--
• KB-1 and KB-1 Plus will be applied at a concentration of approximately 0.0014 to 0.0017 L of
KB-1/KB-1 Plus per gal of injection solution.
o Note that KB-1 Plus was included in the initial UIC permit application but was not
included in the executed permit because it was not an improved injectate. KB-1 Plus has
since become an approved injectate. Its SDS has been reattached.
• KB-1 Primer will be applied at a concentration of 0.00175 lb/gal or 0.0071b/gal for diluted
electron donor or anaerobic chase water, respectively.

o Note that KB-1 Primer was included in the initial UIC permit application but was not
included in the executed permit because it was not an improved injectate. KB-1 Primer
has since become an approved injectate. Its SDS has been reattached.
• Sodium sulfite will be applied at a concentration of 0.00053 lb/gal.
• Sodium bicarbonate will be applied at a concentration of approximately 0.073 to 0.5721b/gal
depending on the injection interval and location.
• Magnesium hydroxide will be applied at a concentration of 0.021 to 0.131 lb/gal depending on
the injection interval.
• A revision of Appendix F (Electron Donor Dosing and Injection Volume Calculations and KB-1
Bioaugmentation Dosing) is provided
(A) The following is a summary of concentrations of the primary injectant materials at the point of
injection:
Treatment
Area
Aquifer
Carbon
Amendment
Diluted
Carbon
Amendment
Concentration
(lb/gal)
ZVI
ZVI
Concentration
(lb/gal)
High
Concentration
Middle
ABC+
0.55
ZVI
0.55
Lower
0.55
ZVI
0.55
Middle
ABC
0.21
--
--
Lower
0.21
--
--
Downgradient
Middle
ABC
0.21
--
--
Lower
0.21
--
--
ABC refers to the product Anaerobic Biochem (ABC®) by Redox Tech, LLC. ABC+ is a mixture
of ABC and zero-valent iron (ZVI). ZVI and ABC will be mixed at a 1:1 basis by weight. Safety
Data Sheets (SDSs) for primary injectant materials (ABC and ZVI) are attached. Information sheets
for these materials are also attached. KB-1 Primer will be applied at a 0.2-0.8 kg to 250-gal ratio
for diluted electron donor or anaerobic chase water. Information sheets for these materials are also
attached.
(B) Source water will be obtained from the onsite fire hydrant, provided approval or the appropriate
applications or permits from the City of Rocky Mount.
(C) See attached Appendix F (Electron Donor Dosing and Injection Volume Calculations and KB-1
Bioaugmentation Dosing) for details on the ABC/ABC+ and KB-1/KB-1 Plus dosing calculations
(Geosyntec, 2021b). ABC was selected as the primary injectant because it has previously been used
on site for the same purpose and was successful in remediating tetrachloroethene (PCE) impacts.
ABC+ (ABC and ZVI mixture) was selected to treat select areas with elevated PCE concentrations,
as ZVI promotes anaerobic biodegradation and reductive dechlorination of halogenated solvents in
groundwater. The ZVI enables immediate reduction by providing short and long-term nutrients to
anaerobic growth. ABC/ABC+ dosing was were adjusted based on the PCE concentrations (higher
concentration areas received higher dosing).
(D) The primary contaminant of concern is PCE. Using ABC/ABC+, degradation of chlorinated
volatile organic compounds (CVOCs) begins via dechlorination. Degradation rates using ZVI are
orders of magnitude greater than natural conditions, thus the degradation of CVOCs does not result
in the formation ethane, ethane, and methane. Ethyl lactate converts to ethanol and lactic acid
through hydrolysis. The following describes the elimination pathway prompted by ABC+ (ABC
with ZVI) and ABC, respectively:
13 -elimination = TCE 4 chloroacetylene 4 acetylene 4 ethane

Hydrogenolysis Pathway = TCE 4 cis-DCE 4 vinyl chloride 4 ethene 4 ethane
(E) N/A
(F) There is potential for these technologies to generate secondary impacts, such as increased
concentrations of methyl ethyl ketone (MEK) in impacted injection areas. During the previous
bioremediation implementation at the Site (2007 to 2008, which utilized ABC), elevated MEK
concentrations were observed in a single monitoring well. Concentrations of MEK typically
attenuate rapidly to background concentrations (Fowler, et. al, 2011). MEK concentrations will be
monitored, as shown in the attached proposed Performance Monitoring Plan (Geosyntec, 2021b).

SiREM
Leading Science • Lasting Solutions
KB-1® Plus Material Safety Data Sheet
Section 1: Material Identification
Trade Name: KB-16Plus
Chemical Family: bacterial mixture
Chemical name: No IUC name for mixture is known to exist
Manufacturer/Supplier: SiREM
130 Research Lane, Suite 2,
Guelph, Ontario,
Canada N 1 G 5G3
For Information call: 519-822-2265 / 1-866-251-1747 x236
Emergency Number: 519-822-2265
Description: Microbial inoculum (non-pathogenic, non -hazardous)
Trade Name: KB-1° Plus
Product Use: Bioremediation of contaminated groundwater.
Date Prepared: 23 October 2008
130 Research Lane, Ste 2
Guelph ON N1G 5G3
[phone]
Section 2: Composition, Information on Ingredients
KB1® Plus is a microbial culture grown in a dilute aqueous mineral salt solution media containing no
hazardous ingredients.
The microbial composition of KB-1°Plus is listed in Table 1.
Table 1. Major Microbial Groups Identified in KB-1® Plus Microbial Inoculum
Dehalococcoides sp.
Geobacter sp.
Methanomethylovorans sp.
Dehalobacter sp.
Dehalogenimonas sp.
Section 3: Hazards Identification:
A review of the available data does not indicate any known health effects related to normal use of this
product.
Section 4: First Aid Measures:
Avoid direct contact with skin and eyes. In any case of any exposure which elicits a response, a
physician should be consulted immediately.
Eye Contact: Flush eyes with water for at least 15 minutes, occasionally lift upper and lower eyelids, if
undue irritation or redness occurs seek medical attention.
Skin Contact: Remove contaminated clothing and wash skin thoroughly with water and antibacterial
soap. Seek medical attention if irritation develops or open wounds are present.
1�(�T B.1'
siremlab.com 1/3

SiREM
Ingestion: Do not induce vomiting, drink several cups of water, seek medical attention.
Inhalation: Remove to fresh air. If not breathing give artificial respiration. In case of labored breathing
give oxygen. Call a physician.
Section 5 - Fire Fighting Measures:
Non-flammable
Flash Point: not applicable
Upper flammable limit: not applicable
Lower flammable limit: not applicable
Section 6 — Accidental Release Procedures
Spilled KB-1® Plus should be soaked up with sorbant and saturated with a 10% bleach solution (prepared
by making a one in ten dilution of diluted standard bleach [normally sold at a strength of 5.25% sodium
hypochlorite] to disinfect affected surfaces. Sorbant should be double bagged and disposed of as
indicated in section 12. After removal of sorbant, area should be washed with 10% bleach solution to
disinfect. If liquid from the culture vessel is present on the fittings, non -designated tubing or exterior of the
stainless steel pressure vessel liquid should be wiped off and the area washed with 10% bleach solution.
Section 7 - Handling and Storage
KB-1® Plus is shipped in stainless steel pressure vessels in a protective over pack. KB-1® Plus should be
handled with care to avoid any spillage. Vessels are shipped with 1 pound per square inch (psi)
pressure; valves should not be opened until connections to appropriate lines for subsurface injection are
in place.
Storage Requirements: Avoid exposing stainless steel pressure vessels to undue temperature
extremes (i.e., temperatures less than 0°C or greater than 30°C may result in harm to the microbial
cultures and damage to the vessels). All valves should be in the closed position when the vessel is not
pressurized or not in use to prevent the escape of gases and to maintain anaerobic conditions in the
vessel. Avoid exposure of the culture to air as the presence of oxygen will kill dechlorinating
microorganisms.
Section 8 - Exposure Controls/Personal Protection
Personal protective equipment:
Skin: Protective gloves (latex, vinyl or nitrile) should be worn.
Eye Protection: Wear appropriate protective eyeglasses or goggles when opening pressure vessels,
valves, or when pressurizing vessels to inject contents into the subsurface.
Respiratory: No respiratory protection is required.
Engineering Controls: Good general room ventilation is expected to be adequate.
Section 9: Physical and Chemical Properties:
Physical State: liquid
Odour: skunky odour
Appearance: dark grey, slightly turbid liquid under anaerobic conditions, pink if exposed to air (oxygen).
Specific gravity: 1
Vapor pressure: not applicable
Vapor density: not applicable
Evaporation rate: not determined
Boiling point: —100° C
Freezing point/melting point: — 0°C
KM' I si•
remlab.com 2/3

SiREM
pH: 6.5-7.5
Solubility: fully soluble in water
Section 10 — Stability and Reactivity Data
Stable and non -reactive.
Maintain under anaerobic conditions to preserve product integrity.
Materials to avoid: none known
Section 11 - Toxicological Information
Potential for Pathogenicity:
KB1® Plus has tested negative (i.e., the organisms are not present) for a variety of pathogenic organisms
listed in Table 2. While there is no evidence that virulent pathogenic organisms are present in KB-1° Plus,
there is potential that certain organisms in KB-1® Plus may have the potential to act as opportunistic (mild)
pathogens, particularly in individuals with open wounds and/or compromised immune systems. For this
reason standard hygienic procedures such as hand washing after use should be observed.
Table 2, Results of Human Pathogen Screening of KB-1°Plus
Organism
Disease(s) Caused
Test result
Salmonella sp.
Typhoid fever, gastroenteritis
Not Detected
Listeria monocytogenes
Listerioses
Not Detected
Vibrio sp.,
Cholera, gastroenteritis
Not Detected
Campylobacter sp.,
Bacterial diarrhea
Not Detected
Clostridia sp.,
Food poisoning, Botulism, tetanus, gas gangrene
Not Detected
Bacillus anthracis
Anthrax
Not Detected
Pseudomonas aeruginosa
Wound infection
Not Detected
Yersinia sp.,
Bubonic Plague, intestinal infection
Not Detected
Yeast and Mold
Candidiasis, Yeast infection etc.
Not Detected
Fecal coliforms
Indicator organisms for many human pathogens diarrhea, urinary
tract infections
Not Detected
Enterococci
Various opportunistic infections
Not Detected
Section 12. Disposal Considerations
Material must be disinfected or sterilized prior to disposal. Consult local regulations prior to disposal.
Section 13 — Transport Information
Non -hazardous, non-pathogenic microbial inoculum
Chemicals, Not Otherwise Indexed (NOI), Non -hazardous
Not subject to TDG or DOT guidelines.
Disclaimer:
The information provided on this MSDS sheet is based on current data and represents our
opinion based on the current standard of practice as to the proper use and handling of this
product under normal, reasonably foreseeable conditions.
Last revised: 12 June 2012
FJi"I m I si•
remlab.com 3/3

"SiREM
SAFETY DATA SHEET
KB-1® Primer
Prepared according to U.S. OSHA, CMA, ANSI, Canadian WHMIS, Australian WorkSafe, Japanese Industrial Standard JIS Z 7250:2000, and European Union REACH Regulations
SECTION 1 - PRODUCT AND COMPANY IDENTIFICATION
1.1 PRODUCT NAME:
PRODUCT CODE:
CHEMICAL FAMILY NAME:
U.N. NUMBER:
U.N. DANGEROUS GOODS CLASS:
1.2 PRODUCT USE:
1.3 SUPPLIER/MANUFACTURER'S NAME:
ADDRESS:
1.4 EMERGENCY PHONE:
BUSINESS PHONE:
WEB SITE:
1.5 DATE OF PREPARATION:
DATE OF LAST REVISION:
KB-1® Primer
N/A
Mixture
None
Not Regulated
For preparation of anaerobic water for use in groundwater remediation.
KB1® products are intended for laboratory research and field
applications for groundwater remediation, and are not intended to be
used as human or animal therapeutics, cosmetics, agricultural or
pesticidal products, food additives, or as household chemicals.
SiREM
130 Stone Road, West, Guelph, Ontario Canada N1G 3Z2
519-515-0840
519-515-0840 (Product Information)
www.siremlab.com
December 05, 2018
New
SECTION 2 - HAZARDS IDENTIFICATION
2.1 Classification of the mixture:
This product does meet the definition of a hazardous substance or preparation as defined by 29 CFR 1910. 1200 AND
the European Union Council Directives 67/548/EEC, 1999/45/EC, 1272/2008/EC, 2015/830/EU and subsequent
Directives.
Component(s) Contributing to Classification(s)
L-Cysteine
2.2 GHS Label elements, including precautionary statements:
Pictogram(s):
None applicable.
Signal Word:
Warning!
GHS Hazard Classification(s):
Acute Toxicity Category 5 (Oral)
Hazard Statement(s):
H303: May be harmful if swallowed
Prevention Statement(s):
None Applicable
Response Statement(s):
P312: Call a POISON CENTER/doctor if you feel unwell.
Storage Statement(s):
None Applicable
Disposal Statement(s):
None Applicable.
2.3 Other Hazards:
This mixture does not meet the criteria for PBT or vPvB in accordance with Annex VII.
December 2018
Page 1 of 8
KB-1
PRIMER
siremlab.com

•• SiREM SAFETY DATA SHEET
KB-1® Primer
SECTION 3 - COMPOSITION and INFORMATION ON INGREDIENTS
3.1 Substances: Not applicable
3.2 Mixtures:
HAZARDOUS INGREDIENTS:
CAS #
EINECS #
Index #
WT %
GHS CLASSIFICATION
L-Cysteine
52-90-4
200-158-2
Not Listed
1-10%
ACUTE TOX. CAT 4 (ORAL)
Balance of other ingredients are non -hazardous or hazardous below the applicable cut-off level.
Additional Information: See SECTION 16 for full classification phrases.
SECTION 4 - FIRST -AID MEASURES
4.1 Description of first aid measures:
Contaminated individuals of chemical exposure must be taken for medical attention if any adverse effect occurs.
Rescuers should be taken for medical attention, if necessary. Take copy of label and SDS to health professional with
contaminated individual.
EYE CONTACT: If product enters the eyes, open eyes while under gentle running water for at least 15 minutes. Seek
medical attention if irritation persists.
SKIN CONTACT: Wash skin thoroughly after handling. Seek medical attention if irritation develops and persists.
Remove contaminated clothing. Launder before re -use.
INHALATION: If breathing becomes difficult, remove victim to fresh air. If necessary, use artificial respiration to
support vital functions. Seek medical attention.
INGESTION: If product is swallowed, call physician or poison control center for most current information. If professional
advice is not available, do not induce vomiting. Never induce vomiting or give diluents (milk or water) to someone who
is unconscious, having convulsions, or who cannot swallow. Seek medical advice. Take a copy of the label and/or
SDS with the victim to the health professional.
4.2 Most important symptoms and effects, both acute and delayed:
May be harmful if swallowed. See section 11 for additional information.
MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Pre-existing skin problems may be aggravated by
prolonged or repeated contact.
4.3 Indication of immediate medical attention and special treatment needed:
Treat symptoms and reduce over -exposure.
SECTION 5 - FIRE -FIGHTING MEASURES
5.1 Extinguishing media:
Use media suitable for surrounding area. Carbon dioxide, foam, dry chemical, halon, water spray.
5.2 Specific hazards arising from the chemical:
No data available for this product.
Explosion Sensitivity to Mechanical Impact: Not Sensitive.
Explosion Sensitivity to Static Discharge: Not Sensitive
Minimum Ignition Energy (M.I.E.) No Data at this time
5.3 Special firefighting Procedure:
Incipient fire responders should wear eye protection. Structural firefighters must wear Self -Contained Breathing
Apparatus and full protective equipment. Isolate materials not yet involved in the fire and protect personnel. Move
containers from fire area if this can be done without risk; otherwise, cool with carefully applied water spray. If possible,
prevent runoff water from entering storm drains, bodies of water, or other environmentally sensitive areas.
December 2018 Page 2 of 8
KB-1
PRIMER
siremlab.com

•• SiREM SAFETY DATA SHEET
KB-1® Primer
SECTION 6 - ACCIDENTAL RELEASE MEASURES
6.1 Personal precautions, protective equipment and emergency procedures:
No action shall be taken involving any personal risk or without suitable training. Do not touch or walk through spilled
material. Avoid breathing dust. Provide adequate ventilation. Use appropriate respirator when ventilation is
inadequate and use personal protective clothing as described in Section 8 of this safety data sheet. See section 11 for
additional information on health hazards.
6.2 Environmental precautions:
No specific data available for this product.
6.3 Methods and material for containment and cleaning up:
Wear suitable protective clothing. Avoid dust formation. Avoid breathing dust. Carefully sweep up and remove. Place
material in a dry container and cover. Remove from the area. Flush spill area with water. Do not let products enter
drains. Dispose of in accordance with applicable Federal, State, and local procedures (see Section 13, Disposal
Considerations).
SECTION 7 - HANDLING and STORAGE
7.1 Precautions for safe handling:
As with all chemicals, avoid getting this product ON YOU or IN YOU. Wash thoroughly after handling this product. Do
not eat, drink, smoke, or apply cosmetics while handling this product. Use in a well -ventilated location. Remove
contaminated clothing immediately
7.2 Conditions for safe storage, including any incompatibilities:
Store in a tightly sealed container in a cool, dry and well -ventilated place. Store away from direct light. Avoid
generation of dust. Do not breathe dust. Wash thoroughly after handling. In case of contact with eyes, rinse
immediately with plenty of water and seek medical advice. Wear suitable protective clothing. Segregate from strong
oxidizing agents, acids, bases.
7.3 Specific end uses:
See section 1.2.
SECTION 8 - EXPOSURE CONTROLS - PERSONAL PROTECTION
8.1. Control parameters:
EXPOSURE LIMITS/GUIDELINES: None established for this product.
8.2 Exposure Controls:
Currently, International exposure limits are not established for the components of this product. Please check with
competent authority in each country for the most recent limits in place.
VENTILATION AND ENGINEERING CONTROLS: Generally not required under normal conditions of use. If method of
use will result in significant dust generation, use in lab hood or under conditions of adequate ventilation.
The following information on appropriate Personal Protective Equipment is provided to assist employers in complying with OSHA
regulations found in 29 CFR Subpart I (beginning at 1910.132) or equivalent standard of Canada, or standards of EU member
states (including EN 149 for respiratory PPE, and EN 166 for face/eye protection), and those of Japan. Please reference applicable
regulations and standards for relevant details.
RESPIRATORY PROTECTION: Maintain airborne contaminant concentrations below guidelines listed above, if applicable.
If necessary, use only respiratory protection authorized in the U.S. Federal OSHA Respiratory Protection Standard (29
CFR 1910.134), equivalent U.S. State standards, Canadian CSA Standard Z94.4-93, the European Standard EN149, or
EU member states.
EYE PROTECTION: Safety glasses or chemical goggles as appropriate to prevent eye contact. If necessary, refer to
U.S. OSHA 29 CFR 1910.133 or appropriate Canadian Standards.
HAND PROTECTION: Use chemical resistant gloves to prevent skin contact. If necessary, refer to U.S. OSHA 29 CFR
1910.138 or appropriate Standards of Canada.
BODY PROTECTION: Use body protection appropriate to prevent contact (e.g. lab coat, overalls). If necessary, refer to
appropriate Standards of Canada, or appropriate Standards of the EU, Australian Standards, or relevant Japanese
Standards.
December 2018 Page 3 of 8
KB-1
PRIMER
siremlab.com

•• SiREM SAFETY DATA SHEET
KB-1® Primer
SECTION 9 - PHYSICAL and CHEMICAL PROPERTIES
9.1 Information on basic physical and chemical properties:
PHYSICAL STATE:
Solid (Granules)
APPEARANCE: White to off-white powder or granules
ODOR: Odorless
ODOR THRESHOLD (PPM): Not Available
pH: 6-8 (aqueous solution)
MELTING / FREEZING POINT (C°): Not Available
BOILING POINT (C°): Not Available
FLASH POINT: Not Available
EVAPORATION RATE (nBuAc = 1): Not Available
FLAMMABILITY (solid, gas): Not Available
FLAMMABLE LIMITS (in air by volume, %): Not Available
VAPOR PRESSURE (mmHg): Not Available
VAPOR DENSITY (AIR=1): Not Available
RELATIVE DENSITY 2.4 to 2.6 g/cm3, depending on formulation
SOLUBILITY IN WATER (%) Soluble
PARTITION COEFFICIENT: N-OCTANOL/WATER: Not Available
AUTOIGNITION TEMPERATURE: Not Available
DECOMPOSITION TEMPERATURE: Not Available
VISCOSITY: Not Available
EXPLOSIVE PROPERTIES: Not Available
OXIDISING PROPERTIES: Not Available
9.2 Other Information:
PACKING DENSITY:
VOC:
Not Available
Not Available
SECTION 10 - STABILITY and REACTIVITY
10.1 Reactivity: See section 10.5.
10.2 Chemical Stability: Product is stable.
10.3 Possibility of Hazardous Reactions: Under normal conditions of storage and use, hazardous reactions will not
occur.
10.4 Conditions to avoid: Contact with incompatibles, exposure to light, and moist air.
10.5 Incompatible materials: Strong oxidizing agents, bases.
10.6 Hazardous Decomposition Products: Carbon monoxide, carbon dioxide, nitrogen oxides, sulfur oxides,
potassium oxides.
SECTION 11 - TOXICOLOGICAL INFORMATION
11.1 Information on Toxicological Effects:
TOXICITY DATA:
L-Cysteine CAS# 52-90-4
Oral LD50 1890 mg/kg Rat
Oral LD50 660 mg/kg Mouse
December 2018 Page 4 of 8
KB-1
PRIMER
siremlab.com

•• SiREM SAFETY DATA SHEET
KB-1® Primer
11.1.2 Mixtures:
Acute toxicity
Acute Toxicity Category 5 (Oral)
Skin corrosion / irritation
Based on available data, the classification criteria are not met
Serious eye damage / irritation
Based on available data, the classification criteria are not met
Respiratory or skin sensitization
Based on available data, the classification criteria are not met
Germ cell mutagenicity
Based on available data, the classification criteria are not met
Carcinogenicity
Based on available data, the classification criteria are not met
Reproductive toxicity
Based on available data, the classification criteria are not met
STOT-single exposure
Based on available data, the classification criteria are not met
STOT-repeated exposure
Based on available data, the classification criteria are not met
Aspiration hazard
Based on available data, the classification criteria are not met
Other Information
POTENTIAL HEALTH HAZARDS OR RISKS FROM EXPOSURE:
ACUTE:
EYE CONTACT: Eye exposure may produce irritation.
SKIN CONTACT: Prolonged or repeated skin exposure may cause irritation.
INHALATION HAZARDS: Inhalation of dusts may cause irritation.
INGESTION HAZARDS: May be harmful if swallowed. May cause gastrointestinal tract irritation.
CHRONIC: None Known
TARGET ORGANS: ACUTE: Organs CHRONIC: None Known
CARCINOGENICITY: None of the ingredients are found on the following lists: FEDERAL OSHA Z LIST, NTP,
CAL/OSHA, IARC and therefore are not considered to be, nor suspected to be a cancer -causing agent by these
agencies.
IRRITANCY OF PRODUCT: Contact with this product can be irritating to skin and eyes.
SENSITIZATION OF PRODUCT: This product is not considered a skin sensitizer.
REPRODUCTIVE TOXICITY INFORMATION: No information concerning the effects of this product and its components
on the human reproductive system.
MUTAGENICITY INFORMATION: This product does not contain a component that is suspected to be a mutagenicity
hazard.
SPECIFIC TARGET ORGAN TOXICITY — SINGLE EXPOSURE: Data not sufficient for classification.
SPECIFIC TARGET ORGAN TOXICITY — REPEATED EXPOSURE: Data not sufficient for classification.
ASPIRATION HAZARD: Not applicable
SECTION 12 - ECOLOGICAL INFORMATION
ALL WORK PRACTICES MUST BE AIMED AT ELIMINATING ENVIRONMENTAL CONTAMINATION.
12.1 Toxicity:
No specific data available on this product.
12.2 Persistence and Degradability:
No specific data available on this product.
12.3 Bioaccumulative Potential:
No specific data available on this product.
12.4 Mobility in Soil:
No specific data available on this product.
12.5 Results of PBT and vPvB Assessment:
No specific data available on this product.
12.6 Other Adverse Effects:
No specific data available on this product.
12.7 Water Endangerment Class:
Not believed to be water endangering in accordance with EU Guideline 91/155-EWG. At present there are no
ecotoxicological assessments for this product.
December 2018 Page 5 of 8
K81
PRIMER
siremlab.com

•• SiREM SAFETY DATA SHEET
KB-1® Primer
SECTION 13 - DISPOSAL CONSIDERATIONS
13.1 Waste Treatment Methods:
Waste disposal must be in accordance with appropriate Federal, State, and local regulations, those of Canada,
Australia, EU Member States and Japan.
SECTION 14 - TRANSPORTATION INFORMATION
14.1 Transport Information:
US DOT; IATA; IMO; ADR:
THIS PRODUCT IS NOT CLASSIFIED AS DANGEROUS GOODS AS DEFINED BY 49 CFR 172.101 BY THE U.S.
DEPARTMENT OF TRANSPORTATION.
PROPER SHIPPING NAME: None
HAZARD CLASS NUMBER and DESCRIPTION: Not Regulated
UN IDENTIFICATION NUMBER: None
PACKING GROUP: None
DOT LABEL(S) REQUIRED: None
NORTH AMERICAN EMERGENCY RESPONSE GUIDEBOOK NUMBER (2016): None
MARINE POLLUTANT: This product does not contain ingredients that are classified by the DOT as a Marine Pollutant
(as defined by 49 CFR 172.101, Appendix B)
TRANSPORT CANADA, TRANSPORTATION OF DANGEROUS GOODS REGULATIONS:
This product is not classified as Dangerous Goods, per regulations of Transport Canada
INTERNATIONAL AIR TRANSPORT ASSOCIATION (IATA):
This product is not classified as Dangerous Goods, by rules of IATA:
INTERNATIONAL MARITIME ORGANIZATION SHIPPING and MARITIME DANGEROUS GOODS CODE SHIPPING
INFORMATION (IMO / IMDG):
This product is not classified as Dangerous Goods.
EUROPEAN AGREEMENT CONCERNING THE INTERNATIONAL CARRIAGE OF DANGEROUS GOODS BY ROAD
(ADR):
This product is not classified by the United Nations Economic Commission for Europe to be dangerous goods.
SECTION 15 - REGULATORY INFORMATION
15.1 Safety, Health and Environmental Regulations/Legislation Specific for the Substance or Mixture:
UNITED STATES REGULATIONS
SARA REPORTING REQUIREMENTS: This product is not subject to the reporting requirements of Sections 302, 304
and 313 of Title III of the Superfund Amendments and Reauthorization Act., as follows: None
TSCA: All components in this product are listed on the US Toxic Substances Control Act (TSCA) inventory of
chemicals.
SARA 311/312:
Acute Health: No Chronic Health: No Fire: No Reactivity: No
U.S. SARA THRESHOLD PLANNING QUANTITY: There are no specific Threshold Planning Quantities for this
product. The default Federal SDS submission and inventory requirement filing threshold of 10,000 lb (4,540 kg) may
apply, per 40 CFR 370.20.
U.S. CERCLA REPORTABLE QUANTITY (RQ): None
CALIFORNIA SAFE DRINKING WATER AND TOXIC ENFORCEMENT ACT (PROPOSITION 65): None of the
ingredients are on the California Proposition 65 lists.
CANADIAN REGULATIONS:
CANADIAN DSL/NDSL INVENTORY STATUS:AII of the components of this product are on the DSL Inventory
CANADIAN ENVIRONMENTAL PROTECTION ACT (CEPA) PRIORITIES SUBSTANCES LISTS: No component of
this product is on the CEPA First Priorities Substance Lists.
CANADIAN WHMIS CLASSIFICATION and SYMBOLS: This product is categorized as per WHMIS 2015 Hazardous
Product Regulations.
December 2018 Page 6 of 8
KB-1
PRIMER
siremlab.com

•• SiREM SAFETY DATA SHEET
KB-1® Primer
EUROPEAN ECONOMIC COMMUNITY INFORMATION:
EU LABELING AND CLASSIFICATION:
Classification of the mixture according to Regulation (EC) No1272/2008. See section 2 for details.
AUSTRALIAN INFORMATION FOR PRODUCT:
AUSTRALIAN INVENTORY OF CHEMICAL SUBSTANCES (AICS) STATUS: Components of this product are listed on
the AICS.
STANDARD FOR THE UNIFORM SCHEDULING OF DRUGS AND POISONS: Not applicable.
JAPANESE INFORMATION FOR PRODUCT:
JAPAN INDUSTRIAL SAFETY AND HEALTH LAW: This product has been classified per the Japan Industrial Safety
and Health Law. See Section 2 for the GHS Classification.
KOREA ACT ON REGISTRATION AND EVALUATION OF CHEMICAL SUBSTANCES (K-REACH): This product has
been classified per K-REACH. See Section 2 for the GHS Classification.
INTERNATIONAL CHEMICAL INVENTORIES:
Listing of the components on individual country Chemical Inventories is as follows:
Asia-Pac: Listed
Australian Inventory of Chemical Substances (AICS): Listed
Korean Existing Chemicals List (ECL): Listed
Japanese Existing National Inventory of Chemical Substances (ENCS): Listed
Philippines Inventory if Chemicals and Chemical Substances (PICCS): Listed
Swiss Giftliste List of Toxic Substances: Listed
U.S. TSCA: Listed
15.2 Chemical Safety Assessment:
A chemical safety assessment has not been performed on this product.
SECTION 16 - OTHER INFORMATION
HMIS Rating (Scale 0-4)
Health hazard: 1
Flammability: 0
Physical Hazard: 0
NFPA Rating (Scale 0-4)
Health hazard: 1
Flammability: 0
Physical Hazard: 0
Caution: HMIS and NFPA ratings are based on a 0-4 rating scale
0= Minimal Hazard
1= Slight
2= Moderate
3= High
4= Extreme
Abbreviations and
ACGIH
CFR
DOT
GHS
HMIS
HCS
IARC
IATA
ICAO
IMDG
IMO
LD50/LC50
NFPA
NIOSH
acronyms
American Conference of Governmental Industrial Hygienists
Code of Federal Regulations
Federal Department of Transportation
The Globally Harmonized System of Classification and Labelling of Chemicals
Hazardous Material Identification System
Hazard Communication Standard
International Agency for Research on Cancer
The International Air Transport Association
The International Civil Aviation Organization
International Maritime Dangerous Goods
International Maritime Organization
Lethal Concentration/Dose, 50 percent
National Fire Protection Association
National Institute for Occupational Safety and Health
December 2018
Page 7 of 8
KB-1
PRIMER
siremlab.com

•• SiREM SAFETY DATA SHEET
KB-1® Primer
NTP National Toxicology Program
OSHA Occupational Safety and Health
PEL OSHA Permissible Exposure Limit
SARA Superfund Amendments and Reauthorization Act
TLV ACGIH Threshold Limit Value
TWA Time -Weighted Average
Acute Tox Acute Toxicity
Skin Corr Skin Corrosion
PREPARED BY: Chris Eigbrett MSDS to GHS Compliance
History Log:
December 05, 2018 - Document creation
End of SDS Sheet
December 2018 Page 8 of 8
KB-1
PRIMER
siremlab.com

Appendix F. Electron Donor Dosing and Injection Volume Calculations
Former Schlage Lock Plant
Rocky Mount, North Carolina
Geosyntec°
consultants
Geosyntec Consultants of NC, P.C.
Treatment
Area
Treatment
Geology
Treatment
Interval
(ft BLS)
Number
of Location of
Injection Injection Points
Points
Porosity
(Equal to
Effective
Porosity)
Target
ROI
(ft)
Injection
Location
Area
z
n'(ROI)
(ft)
Total
Injection
Interval
(feet)
Number of
2-ft
Injection
Intervals
Total
Injection
Area
Injection
Location
Area *
Number of
Injection
Points
(ft3)
Total
Treatment
Volume for
the Target
ROI
Total Injection
Area '
Injection
Interval
(ft)
Treatm ent Pore
Volume
Total Trealm ent
Volume` Porosity
3
' 7.481 gal/ft
(gal)
Electron Donor
Required Based
on Treatment
Pore Volume
Dosing
Treatm ent Pore
Volume `
Dosing
3
(0.3 Ib/ft)
(Ib)
Amendment
Volume
Electron Donor
Required / 60%
Electron Donor
/ Specific
Weight of
Amendment
(Rounded Up to
Nearest 10)
(gal)
ZVI Mass
Amendment
Volume`
Specific Weight
of Amendment
(1:1 by weight
electron
donocZVl)
(Ib)
Pore Volume
Displacement
Total Injection
Volume
(Based on 14-ft ROI)
Treatment Pore
Volume * Pore
Volume
Displacement
(Round Up to
Nearest 1 gal)
(gal)
Amendment
Dilution
(1:15 or
1:20)
Total Diluted
Amendment
Volume
Amendment
Volume `
Amendment
Dilution
(gal)
Diluted
Amendment
Concentration
Amendment
Volume'
Specific Weight
of Am endment/
Total Diluted
Amendment
Volume
(Ib/gal)
Total Chase
Water Volume
oInjection
Volume -Total
Diluted
Amendment
Volume
(gal)
Per Location Per Location
Diluted Chase Water
Amendment Volume
Total Diluted Total Chase
Amendment Water Volume/
Volume / No. No. of Inj.
of Inj. Points Points
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1 gal)
(gal) (gal)
Per Injection Per Injection
Interval
Interval Diluted
Chase Water
Amendment
Volume
Total Chase
Total Diluted Water
Amendment Volume/No.
Volume / No. of Inj. of Inj.
Intervals Intervals
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1
gal)
(gal) (gal)
High
Concentration
Area
(HC 1, HC2,
HC3, HC4)
High Concentration
Area - Middle
Aquifer - ABC+ (with
ZVI)
Middle
Aquifer
16
to
32
11 HC2 - MW75S
0.25
14
616
16
8
6,773
108,372
202,683
8,129
1,660
13,612
0.17
34,457
15
24,900
0.55
9,557
2,264
869
283
109
16
to
30
4 HC3 - MW78S
0.25
14
616
14
7
2,463
34,482
64,490
2,587
530
4,346
0.17
10,964
15
7,950
0.55
3,014
1,988
754
284
108
MiddleAguifer Totals
(with ZVI)
15
---
116
9,236
142,855
267,174
10,716
2,190
17,958
---
45,421
---
32,850
0.55
12,571
--
--
--
--
High Concentration Area - Lower Aquifer - ABC+ (with ZVI)
Lower
Aquifer
34
to
50
3 HC3 - MW78D
0.25
14
616
16
8
1,847
29,556
55,277
2,217
460
3,772
0.17
9,398
15
6,900
0.55
2,498
2.300
833
288
105
LowerAqu"er Totals
(with ZVI)
3
---
24
1,847
29,556
55,277
2,217
460
3,772
---
9,398
---
6,900
0.55
2,498
--
--
--
High Concentration Area - Middle Aquifer - ABC ONLY
Middle
Aquifer
18
to
32
4 HC1 - MW76S
0.25
14
616
14
7
2,463
34,482
64,490
2,587
530
0
0.20
12,899
20
10,600
0.41
2,299
2,650
575
379
83
14
to
36
2 HC1 - MW76S
0.25
14
616
22
11
1,232
27,093
50,671
2,032
420
0
0.20
10,135
20
8,400
0.41
1,735
4,200
868
382
79
19
to
31
10 HC2 - MW75S
0.25
14
616
12
6
6,158
73,890
138,193
5,543
1,130
0
0.20
27,639
20
22,600
0.41
5,039
2,260
504
377
84
22
to
36
4 HC2 - MW75S
0.25
14
616
14
7
2,463
34,482
64,490
2,587
530
0
0.20
12,899
20
10,600
0.41
2,299
2,650
575
379
83
21
to
33
5 HC2 - MW75S
0.25
14
616
12
6
3,079
36,945
69,097
2,771
570
0
0.20
13,820
20
11,400
0.41
2,420
2,280
484
380
81
18
to
30
6 HC3 - MW78S
0.25
14
616
12
6
3,695
44,334
82,916
3,326
680
0
0.20
16,584
20
13,600
0.41
2,984
2,267
498
378
83
17
to
29
5 HC3 - MW78S
0.25
14
616
12
6
3,079
36,945
69,097
2,771
570
0
0.20
13,820
20
11,400
0.41
2,420
2,280
484
380
81
Middle Aquifer Totas o
ZVI)
36
---
234
22,167
288,172
538,954
21, 616
4,430
0
---
107, 796
---
88, 600
0.41
19,196
--
--
--
High Concentration Area - Lower Aquifer - ABC ONLY
Lower
Aquifer
40
to
50
3 HC1 - MW76D
0.25
14
616
10
5
1,847
18,473
34,548
1,386
290
0
0.20
6,910
20
5,800
0.41
1,110
1,934
370
387
74
38
to
50
3 HC1 - MW76D
0.25
14
616
12
6
1,847
22,167
41,458
1,663
340
0
0.20
8,292
20
6,800
0.41
1,492
2,267
498
378
83
34
to
50
5 HC3 - MW78D
0.25
14
616
16
8
3,079
49,260
92,129
3,695
760
0
0.20
18,426
20
15,200
0.41
3,226
3,040
646
380
81
26
to
46
3 HC4 - MW30
0.25
14
616
20
10
1,847
36,945
69,097
2,771
570
0
0.20
13,820
20
11,400
0.41
2,420
3,800
807
380
81
Y Lower Aquer ata s
(Na ZVI)
14
---
103
8, 621
126,845
237,232
9,515
1,960
0
---
47,448
---
39,200
0.41
8,248
--
--
--
--
HighConcentration Area
Totals
68 -
-
-
-
-
477
41,871
587,428
I,098,636
44,063
9,040
21,730
---
210,063
---
167,550
--
42,513
--
-
-
--
Treatment
Area
Treatment
Geology
Treatment
Interval
(ft BLS)
Number
of Location of
Injection Injection Points
Points
Porosity
(Equal to
Effective
Porosity)
Target
Width
(14-ft ROI
x2)
(ft)
Target
Length
(ft)
Total
Injection
Interval
(feet)
Number of
2-ft
Injection
Intervals
Total Target
Area
Target
Width'
Target
Length
(ft)
Total
Treatment
Volume for
theTarget
Area
TotalTarget
Area *
Injection
Interval
(ft)
Treatm ent Pore
Volume
TotalTreatm ent
Volume' Porosity
a
* 7.481 gal/ft
(gal)
Electron Donor
Required Based
on Treatment
Pore Volume
Dosing
Treatm ent Pore
Volume *
Dosing
(0.3 Ib/ft3)
(lb)
Amendment
Volume
Electron Donor
Required / 60%
Electron Donor
/ Specific
Weight of
Ameudmeut
(Rounded Up to
Nearest 10)
(gal)
ZVI Mass
Amendment
Volume *
Specific Weight
of Amendment
(lb)
Pore Volume
Displacement
Total Injection
Volume
(Based on 14-ftROI)Volume
n'(ROIf * Total
Injection Interval`
Number of Injection
Points' Porosity`
3
7.481 gal/ft `Pore
Volume
Displacement
(Round Up to
Nearest 1 gal)
(gal)
Ameudmeut
Dilution
(120)
.
Total Diluted
Amendment
Amendment
Volume *
Amendment
Dilution
(gal)
Diluted
Amendment
Concentration
Ameudm ent
Volume'
Specific Weight
p
of Amendment /
Total Diluted
Amendment
Volume
(Ib/gal)
Total Chase
Water Volume
Total Injection
Volume -Total
Diluted
Amendment
Volume
(gal)
Per Location Per Location
Diluted Chase Water
Amendment Volume
Total Diluted Total Chase
Amendment Water Volume/
Volume / No. No. of Inj.
of Inj. Points Points
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1 gal)
(gal) (gal)
Per Injection Per Injection
Interval
Interval Diluted
Chase Water
Amendment Volume
Total Chase
Total Diluted Water
Amendment Volume/No.
Volume / No. of Inj. of Inj.
Intervals Intervals
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1
gal)
(gal) (gal)
Downgradrent
Area
(DG1, DG2,
DG3)
Dowugradieut Area - Middle Aquifer - ABC ONLY
Middle
Aquifer
12
to
22
13 DG1 - MW37
0.25
28
353
10
5
9,884
98,840
184,856
7,414
1,510
0
0.25
37,428
20
30,200
0.41
7,228
2,324
556
465
112
12
to
24
1 DG1 - MW37
0.25
28
27
12
6
756
9,072
16,967
680
140
0
0.25
3,455
20
2,800
0.41
655
2,800
655
467
110
Middle Agu" er Totals
14 ---
---
--
---
---
71
10,640
107,912
201,822
8,094
1,650
0
---
40,883
---
33,000
0.41
7,883
--
--
--
Dowugradieut Area - Lower Aquifer - ABC ONLY
Lower
Aquifer
25
to
41
4 DG1 - MW47D
0.25
28
110
16
8
3,080
49,280
92,166
3,696
760
0
0.25
18,426
20
15,200
0.41
3,226
3,800
807
475
101
35
to
45
4 DG2 - MW74D
0.25
28
110
10
5
3,080
30,800
57,604
2,310
470
0
0.25
11,517
20
9,400
0.41
2,117
2,350
530
470
106
38
to
50
DG3 - North of
9 MW70D
0.25
28
249
12
6
6,972
83,664
156,473
6,276
1,280
0
0.25
31,094
20
25,600
0.41
5,494
2,844
611
474
102
40
to
50
DG3 - around
3 MW70D
0.25
28
81
10
5
2,268
22,680
42,417
1,701
350
0
0.25
8,638
20
7,000
0.41
1,638
2,333
546
467
110
LawerAgu"er Totals
20 ---
---
--
---
---
121
15,400
186,424
348,659
13,984
2,860
0
---
69,675
---
57,200
0.41
12,475
--
--
--
DowngradientArea
Totals
34 -
-
-
--
-
192
26,040
294,336
550,482
22,078
4,510
0
-
110,558
-
90,200
-
20,358
-
-
--
-
Total Injection Amounts
102
---
-
669
67,911
881,764
1,649,118
66,141
13,550
21,730
---
320,621
---
257,750
--
62,871
--
--
--
--
Notes:
1. ft BLS indicates feet below land surface.
2. x indicates 3.14159265359.
3. ROI indicates radius of influence.
4. ftz indicates square feet.
5 ft3 indicates cubic feet.
6. gal indicates gallons.
7. Ib indicates pound.
8. ROI indicates radius of influence.
9. ZVI indicates zero valent iron.
10. Injection calculations are divided into two areas, based on how the Total Treatment Volume was calculated (High Concentration Area and Downgradieut Area).
Page 1 of 1
Geosyntec Consultants of NC, PC

Appendix F. KB-1® Bioaugmentation Dosing
Former Schlage Lock Plant
Rocky Mount, North Carolina
Geosyntec°
consultants
Geosyntec Consultants of NC, P.C.
Variable
Value
Unit/Notes
Treatment Pore Volume
1,649,118
Gallon (gal)
6,242,572
Liter (L; 3.8754 L per gal)
KB-1® Dosing
7.14E-05
Liter of KB-1® per Liter treatment pore volume
(2.5 L of KB-1 per 35,000 L of groundwater)
KB-1® Volume for Pore Volume
446
L
Middle Aquifer:
High Concentration Area
806,127
Treatment Pore Volume (gal)
3,051,514
Treatment Pore Volume (L)
218
KB-1 Requirement (rounded up to nearest whole number)
350
Total Injection Intervals
0.623
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.650
KB-1 (L) per injection interval (rounded up to nearest
0.05)
227.50
Total KB-1 (L) to Inject
Middle Aquifer:
Downgradient Area
201,822
Treatment Pore Volume (gal)
763,979
Treatment Pore Volume (L)
55
KB-1 Requirement (rounded up to nearest whole number)
71
Total Injection Intervals
0.775
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.800
KB-1 (L) per injection interval (rounded up to nearest
0.05)
56.8
Total KB-1 (L) to Inject
Lower Aquifer:
High Concentration Area
292,509
Treatment Pore Volume (gal)
1,107,264
Treatment Pore Volume (L)
80
KB-1 Requirement (rounded up to nearest whole number)
127
Total Injection Intervals
0.630
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.650
KB-1 (L) per injection interval (rounded up to nearest
0.05)
82.55
Total KB-1 (L) to Inject
Lower Aquifer:
Downgradient Area
348,659
Treatment Pore Volume (gal)
1,319,816
Treatment Pore Volume (L)
95
KB-1 Requirement (rounded up to nearest whole number)
121
Total Injection Intervals
0.785
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.800
KB-1 (L) per injection interval (rounded up to nearest
0.05)
96.8
Total KB-1 (L) to Inject
Total KB-1 Volume
463.65
Sum of individual KB-1 volumes (L) for each aquifer and
aquifer area.
Page 1 of 1 Geosyntec Consultants of NC, PC

4. INJECTION PROCEDURE — Per 15A NCAC 02C .0225(0(71. submit a table with a detailed
description of the proposed injection procedure that includes the following:
(A) The proposed average and maximum daily rate and quantity of injectant;
(B) The average maximum injection pressure expressed in units of pounds per square inch (psi);
and
(C) The total or estimated total volume to be injected.
Modification Description: Modifications include the reduction in total injection volume. It's
estimated that up to approximately 325,000 gal total will be injection (Refer to the attached
Appendix F. Electron Donor Dosing and Injection Volume Calculations for revisions).
A
Injection Timelines — Proposed
Inj.
Rate
Injection Locations
Operating at Once
Injection Gal
per Day
Average
DPT - ABC+
7.8
1
2,800
DPT - ABC
4
6
8,640
Injection Timelines — Proposed
Inj.
Rate
Injection Locations
Operating at Once
Injection Gal
per Day
Maximum
DPT - ABC+
15
1
5,400
DPT - ABC
10
10
36,000
Refer to the attached Appendix F. Electron Donor Dosing and Injection Volume Calculations
(Geosyntec, 2021b) for injection volume details. Proposed maximum rates are not anticipated to
be implemented at all active injection locations; however, historical injection information
indicated injection rates above 10 gallons per minute are possible.
A process flow diagram (PFD) for the ABC and ABC+ injection process is provided on the
attached Figures 8 and 9 (Geosyntec, 2021b). All injections will occur from the bottom up.
(B) Injection pressure: 5-100 psi (based on historical injection information)
(C) Up to 550,000 gal (Refer to the attached Appendix F. Electron Donor Dosing and Injection
Volume Calculations (Geosyntec, 2021b) for design injection volume)

Appendix F. Electron Donor Dosing and Injection Volume Calculations
Former Schlage Lock Plant
Rocky Mount, North Carolina
Geosyntec°
consultants
Geosyntec Consultants of NC, P.C.
Treatment
Area
Treatment
Geology
Treatment
Interval
(ft BLS)
Number
of Location of
Injection Injection Points
Points
Porosity
(Equal to
Effective
Porosity)
Target
ROI
(ft)
Injection
Location
Area
z
n'(ROI)
(ft)
Total
Injection
Interval
(feet)
Number of
2-ft
Injection
Intervals
Total
Injection
Area
Injection
Location
Area *
Number of
Injection
Points
(ft3)
Total
Treatment
Volume for
the Target
ROI
Total Injection
Area '
Injection
Interval
(ft)
Treatm ent Pore
Volume
Total Trealm ent
Volume` Porosity
3
' 7.481 gal/ft
(gal)
Electron Donor
Required Based
on Treatment
Pore Volume
Dosing
Treatm ent Pore
Volume `
Dosing
3
(0.3 Ib/ft)
(Ib)
Amendment
Volume
Electron Donor
Required / 60%
Electron Donor
/ Specific
Weight of
Amendment
(Rounded Up to
Nearest 10)
(gal)
ZVI Mass
Amendment
Volume`
Specific Weight
of Amendment
(1:1 by weight
electron
donocZVl)
(Ib)
Pore Volume
Displacement
Total Injection
Volume
(Based on 14-ft ROI)
Treatment Pore
Volume * Pore
Volume
Displacement
(Round Up to
Nearest 1 gal)
(gal)
Amendment
Dilution
(1:15 or
1:20)
Total Diluted
Amendment
Volume
Amendment
Volume `
Amendment
Dilution
(gal)
Diluted
Amendment
Concentration
Amendment
Volume'
Specific Weight
of Am endment/
Total Diluted
Amendment
Volume
(Ib/gal)
Total Chase
Water Volume
oInjection
Volume -Total
Diluted
Amendment
Volume
(gal)
Per Location Per Location
Diluted Chase Water
Amendment Volume
Total Diluted Total Chase
Amendment Water Volume/
Volume / No. No. of Inj.
of Inj. Points Points
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1 gal)
(gal) (gal)
Per Injection Per Injection
Interval
Interval Diluted
Chase Water
Amendment
Volume
Total Chase
Total Diluted Water
Amendment Volume/No.
Volume / No. of Inj. of Inj.
Intervals Intervals
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1
gal)
(gal) (gal)
High
Concentration
Area
(HC 1, HC2,
HC3, HC4)
High Concentration
Area - Middle
Aquifer - ABC+ (with
ZVI)
Middle
Aquifer
16
to
32
11 HC2 - MW75S
0.25
14
616
16
8
6,773
108,372
202,683
8,129
1,660
13,612
0.17
34,457
15
24,900
0.55
9,557
2,264
869
283
109
16
to
30
4 HC3 - MW78S
0.25
14
616
14
7
2,463
34,482
64,490
2,587
530
4,346
0.17
10,964
15
7,950
0.55
3,014
1,988
754
284
108
MiddleAguifer Totals
(with ZVI)
15
---
116
9,236
142,855
267,174
10,716
2,190
17,958
---
45,421
---
32,850
0.55
12,571
--
--
--
--
High Concentration Area - Lower Aquifer - ABC+ (with ZVI)
Lower
Aquifer
34
to
50
3 HC3 - MW78D
0.25
14
616
16
8
1,847
29,556
55,277
2,217
460
3,772
0.17
9,398
15
6,900
0.55
2,498
2.300
833
288
105
LowerAqu"er Totals
(with ZVI)
3
---
24
1,847
29,556
55,277
2,217
460
3,772
---
9,398
---
6,900
0.55
2,498
--
--
--
High Concentration Area - Middle Aquifer - ABC ONLY
Middle
Aquifer
18
to
32
4 HC1 - MW76S
0.25
14
616
14
7
2,463
34,482
64,490
2,587
530
0
0.20
12,899
20
10,600
0.41
2,299
2,650
575
379
83
14
to
36
2 HC1 - MW76S
0.25
14
616
22
11
1,232
27,093
50,671
2,032
420
0
0.20
10,135
20
8,400
0.41
1,735
4,200
868
382
79
19
to
31
10 HC2 - MW75S
0.25
14
616
12
6
6,158
73,890
138,193
5,543
1,130
0
0.20
27,639
20
22,600
0.41
5,039
2,260
504
377
84
22
to
36
4 HC2 - MW75S
0.25
14
616
14
7
2,463
34,482
64,490
2,587
530
0
0.20
12,899
20
10,600
0.41
2,299
2,650
575
379
83
21
to
33
5 HC2 - MW75S
0.25
14
616
12
6
3,079
36,945
69,097
2,771
570
0
0.20
13,820
20
11,400
0.41
2,420
2,280
484
380
81
18
to
30
6 HC3 - MW78S
0.25
14
616
12
6
3,695
44,334
82,916
3,326
680
0
0.20
16,584
20
13,600
0.41
2,984
2,267
498
378
83
17
to
29
5 HC3 - MW78S
0.25
14
616
12
6
3,079
36,945
69,097
2,771
570
0
0.20
13,820
20
11,400
0.41
2,420
2,280
484
380
81
Middle Aquifer Totas o
ZVI)
36
---
234
22,167
288,172
538,954
21, 616
4,430
0
---
107, 796
---
88, 600
0.41
19,196
--
--
--
High Concentration Area - Lower Aquifer - ABC ONLY
Lower
Aquifer
40
to
50
3 HC1 - MW76D
0.25
14
616
10
5
1,847
18,473
34,548
1,386
290
0
0.20
6,910
20
5,800
0.41
1,110
1,934
370
387
74
38
to
50
3 HC1 - MW76D
0.25
14
616
12
6
1,847
22,167
41,458
1,663
340
0
0.20
8,292
20
6,800
0.41
1,492
2,267
498
378
83
34
to
50
5 HC3 - MW78D
0.25
14
616
16
8
3,079
49,260
92,129
3,695
760
0
0.20
18,426
20
15,200
0.41
3,226
3,040
646
380
81
26
to
46
3 HC4 - MW30
0.25
14
616
20
10
1,847
36,945
69,097
2,771
570
0
0.20
13,820
20
11,400
0.41
2,420
3,800
807
380
81
Y Lower Aquer ata s
(Na ZVI)
14
---
103
8, 621
126,845
237,232
9,515
1,960
0
---
47,448
---
39,200
0.41
8,248
--
--
--
--
HighConcentration Area
Totals
68 -
-
-
-
-
477
41,871
587,428
I,098,636
44,063
9,040
21,730
---
210,063
---
167,550
--
42,513
--
-
-
--
Treatment
Area
Treatment
Geology
Treatment
Interval
(ft BLS)
Number
of Location of
Injection Injection Points
Points
Porosity
(Equal to
Effective
Porosity)
Target
Width
(14-ft ROI
x2)
(ft)
Target
Length
(ft)
Total
Injection
Interval
(feet)
Number of
2-ft
Injection
Intervals
Total Target
Area
Target
Width'
Target
Length
(ft)
Total
Treatment
Volume for
theTarget
Area
TotalTarget
Area *
Injection
Interval
(ft)
Treatm ent Pore
Volume
TotalTreatm ent
Volume' Porosity
a
* 7.481 gal/ft
(gal)
Electron Donor
Required Based
on Treatment
Pore Volume
Dosing
Treatm ent Pore
Volume *
Dosing
(0.3 Ib/ft3)
(lb)
Amendment
Volume
Electron Donor
Required / 60%
Electron Donor
/ Specific
Weight of
Ameudmeut
(Rounded Up to
Nearest 10)
(gal)
ZVI Mass
Amendment
Volume *
Specific Weight
of Amendment
(lb)
Pore Volume
Displacement
Total Injection
Volume
(Based on 14-ftROI)Volume
n'(ROIf * Total
Injection Interval`
Number of Injection
Points' Porosity`
3
7.481 gal/ft `Pore
Volume
Displacement
(Round Up to
Nearest 1 gal)
(gal)
Ameudmeut
Dilution
(120)
.
Total Diluted
Amendment
Amendment
Volume *
Amendment
Dilution
(gal)
Diluted
Amendment
Concentration
Ameudm ent
Volume'
Specific Weight
p
of Amendment /
Total Diluted
Amendment
Volume
(Ib/gal)
Total Chase
Water Volume
Total Injection
Volume -Total
Diluted
Amendment
Volume
(gal)
Per Location Per Location
Diluted Chase Water
Amendment Volume
Total Diluted Total Chase
Amendment Water Volume/
Volume / No. No. of Inj.
of Inj. Points Points
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1 gal)
(gal) (gal)
Per Injection Per Injection
Interval
Interval Diluted
Chase Water
Amendment Volume
Total Chase
Total Diluted Water
Amendment Volume/No.
Volume / No. of Inj. of Inj.
Intervals Intervals
(Round Up to (Round Up to
Nearest 1 gal) Nearest 1
gal)
(gal) (gal)
Downgradrent
Area
(DG1, DG2,
DG3)
Dowugradieut Area - Middle Aquifer - ABC ONLY
Middle
Aquifer
12
to
22
13 DG1 - MW37
0.25
28
353
10
5
9,884
98,840
184,856
7,414
1,510
0
0.25
37,428
20
30,200
0.41
7,228
2,324
556
465
112
12
to
24
1 DG1 - MW37
0.25
28
27
12
6
756
9,072
16,967
680
140
0
0.25
3,455
20
2,800
0.41
655
2,800
655
467
110
Middle Agu" er Totals
14 ---
---
--
---
---
71
10,640
107,912
201,822
8,094
1,650
0
---
40,883
---
33,000
0.41
7,883
--
--
--
Dowugradieut Area - Lower Aquifer - ABC ONLY
Lower
Aquifer
25
to
41
4 DG1 - MW47D
0.25
28
110
16
8
3,080
49,280
92,166
3,696
760
0
0.25
18,426
20
15,200
0.41
3,226
3,800
807
475
101
35
to
45
4 DG2 - MW74D
0.25
28
110
10
5
3,080
30,800
57,604
2,310
470
0
0.25
11,517
20
9,400
0.41
2,117
2,350
530
470
106
38
to
50
DG3 - North of
9 MW70D
0.25
28
249
12
6
6,972
83,664
156,473
6,276
1,280
0
0.25
31,094
20
25,600
0.41
5,494
2,844
611
474
102
40
to
50
DG3 - around
3 MW70D
0.25
28
81
10
5
2,268
22,680
42,417
1,701
350
0
0.25
8,638
20
7,000
0.41
1,638
2,333
546
467
110
LawerAgu"er Totals
20 ---
---
--
---
---
121
15,400
186,424
348,659
13,984
2,860
0
---
69,675
---
57,200
0.41
12,475
--
--
--
DowngradientArea
Totals
34 -
-
-
--
-
192
26,040
294,336
550,482
22,078
4,510
0
-
110,558
-
90,200
-
20,358
-
-
--
-
Total Injection Amounts
102
---
-
669
67,911
881,764
1,649,118
66,141
13,550
21,730
---
320,621
---
257,750
--
62,871
--
--
--
--
Notes:
1. ft BLS indicates feet below land surface.
2. x indicates 3.14159265359.
3. ROI indicates radius of influence.
4. ftz indicates square feet.
5 ft3 indicates cubic feet.
6. gal indicates gallons.
7. Ib indicates pound.
8. ROI indicates radius of influence.
9. ZVI indicates zero valent iron.
10. Injection calculations are divided into two areas, based on how the Total Treatment Volume was calculated (High Concentration Area and Downgradieut Area).
Page 1 of 1
Geosyntec Consultants of NC, PC

Appendix F. KB-1® Bioaugmentation Dosing
Former Schlage Lock Plant
Rocky Mount, North Carolina
Geosyntec°
consultants
Geosyntec Consultants of NC, P.C.
Variable
Value
Unit/Notes
Treatment Pore Volume
1,649,118
Gallon (gal)
6,242,572
Liter (L; 3.8754 L per gal)
KB-1® Dosing
7.14E-05
Liter of KB-1® per Liter treatment pore volume
(2.5 L of KB-1 per 35,000 L of groundwater)
KB-1® Volume for Pore Volume
446
L
Middle Aquifer:
High Concentration Area
806,127
Treatment Pore Volume (gal)
3,051,514
Treatment Pore Volume (L)
218
KB-1 Requirement (rounded up to nearest whole number)
350
Total Injection Intervals
0.623
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.650
KB-1 (L) per injection interval (rounded up to nearest
0.05)
227.50
Total KB-1 (L) to Inject
Middle Aquifer:
Downgradient Area
201,822
Treatment Pore Volume (gal)
763,979
Treatment Pore Volume (L)
55
KB-1 Requirement (rounded up to nearest whole number)
71
Total Injection Intervals
0.775
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.800
KB-1 (L) per injection interval (rounded up to nearest
0.05)
56.8
Total KB-1 (L) to Inject
Lower Aquifer:
High Concentration Area
292,509
Treatment Pore Volume (gal)
1,107,264
Treatment Pore Volume (L)
80
KB-1 Requirement (rounded up to nearest whole number)
127
Total Injection Intervals
0.630
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.650
KB-1 (L) per injection interval (rounded up to nearest
0.05)
82.55
Total KB-1 (L) to Inject
Lower Aquifer:
Downgradient Area
348,659
Treatment Pore Volume (gal)
1,319,816
Treatment Pore Volume (L)
95
KB-1 Requirement (rounded up to nearest whole number)
121
Total Injection Intervals
0.785
Liter of KB-1 per injection interval (rounded to nearest
0.001)
0.800
KB-1 (L) per injection interval (rounded up to nearest
0.05)
96.8
Total KB-1 (L) to Inject
Total KB-1 Volume
463.65
Sum of individual KB-1 volumes (L) for each aquifer and
aquifer area.
Page 1 of 1 Geosyntec Consultants of NC, PC

6. WELL CONSTRUCTION DETAILS — Per 15A NCAC 02C .0225(1)(10). submit the following
information in tabular or schematic form as appropriate for each item:
(A) number and depth of injection wells;
(B) number and depth of borings if using multi -level or "nested" well systems;
(C) indication whether the injection wells are existing or proposed;
(D) depth and type of casing;
(E) depth and type of screen material;
(F) depth and type of grout;
(G) indication whether the injection wells are permanent or temporary "direct push" points; and
(H) plans and specifications of the surface and subsurface construction details.
Modification description: The number of temporary injection locations has been increased from
89 to 102. This occurred because at each location where the Middle and Lower Aquifers are to
be treated, separate boreholes will be used to target each aquifer. Revised injection interval tables
(Tables 3 and 4) are attached.
(A) See the injection interval tables (Tables 3 and 4) attached (Geosyntec, 2021b).
(B) N/A
(C) N/A
(D) N/A
(E) N/A
(F) N/A
(G) Temporary "direct push" points
(H) N/A

Table 3. Injection Location Coordinates and Treatment Intervals
Allegion Rocky Mount
Rocky Mount, North Carolina
Geosyntec °
consultants
Geosyntec Consultants of NC, P.C.
Injection Area
DPT
Injection
Location ID
Target Aquifer(s)
ZVI?
Treatment
Interval
(ft BLS)
Monitoring Well(s)
Used for Design
Primary PCE
Concentration(s)
(µg/L)
Notes
High Concentration Injection Locations
High
Concentration
Area 1
(HC1)
HC1-01
Middle / Lower
18 to 32 /
40 to 50
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-02
Middle / Lower
18 to 32 /
38 to 50
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-03
Middle / Lower
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-04
Middle / Lower
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-05
Middle / Lower
14 to 36 /
40 to 50
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
HC1-06
Middle / Lower
MW-76S
5,630
Separate injection locations for Middle and Lower Aquifer
High
Concentration
Area2
(HC2)
HC2-01
Middle
✓
16 to 32
MW-75S
103,000
HC2-02
Middle
✓
MW-75S
103,000
HC2-03
Middle
✓
MW-75S
103,000
HC2-04
Middle
✓
MW-75S
103,000
HC2-05
Middle
✓
MW-75S
103,000
HC2-06
Middle
✓
MW-75S
103,000
HC2-07
Middle
✓
MW-75S
103,000
HC2-08
Middle
✓
MW-75S
103,000
HC2-09
Middle
✓
MW-75S
103,000
HC2-10
Middle
✓
MW-75S
103,000
HC2-11
Middle
✓
MW-75S
103,000
HC2-12
Middle
19 to 31
MW-75S
103,000
HC2-13
Middle
MW-75S
103,000
HC2-14
Middle
MW-75S
103,000
HC2-15
Middle
MW-75S
103,000
HC2-16
Middle
22 to 36
MW-22
6,550
HC2-17
Middle
MW-22
6,550
HC2-18
Middle
MW-22
6,550
HC2-19
Middle
MW-75S
103,000
HC2-20
Middle
21 to 33
MW-75S
103,000
HC2-21
Middle
MW-75S
103,000
HC2-22
Middle
MW-75S
103,000
HC2-23
Middle
MW-76S
5,630
HC2-24
Middle
MW-76S
5,630
HC2-25
Middle
19 to 31
MW-76S
5,630
HC2-26
Middle
MW-75S
103,000
HC2-27
Middle
MW-75S
103,000
HC2-28
Middle
MW-75S
103,000
HC2-29
Middle
MW-75S
103,000
HC2-30
Middle
MW-75S
103,000
High
Concentration
Area 3
(HC3)
HC3-01
Middle
✓
16 to 30
MW-78S
22,800
HC3-01
Lower
34 to 50
MW-78D
8,900
Lower injection interval at HC3-01 will not receive ZVI
HC3-02
Middle
.716
to 30
MW-78S
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
Lower
34 to 50
MW-78D
HC3-03
Middle / Lower
✓
16 to 30 / 34
to 50
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-04
Middle / Lower
✓
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-05
Middle
18 to 30
MW-78S
22,800
HC3-06
Middle
MW 78S
22,800
HC3-07
Middle
18 to 30
MW-78S
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
Lower
✓
34 to 50
MW-78D
HC3-08
Middle / Lower
18 to 30 / 34
to 50
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-09
Middle / Lower
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-10
Middle / Lower
MW-78S / MW-78D
22,800 / 8,900
Separate injection locations for Middle and Lower Aquifer
HC3-11
Middle
17 to 29
MW-78S
22,800
HC3-12
Middle
MW-78S
22,800
HC3-13
Middle
MW-78S
22,800
HC3-14
Middle
MW-58S
5,400
HC3-15
Middle
MW-58S
5,400
High
Concentration
Area 4
(HC4)
HC4-01
Lower
26 to 46
MW-30
3,260
HC4-02
Lower
MW-30
3,260
HC4-03
Lower
MW-30
3,260
Downgradient Injection Locations
Downgradient
Area 1
(DGl)
DG1-01
Middle
12 to 22
MW-37S
474
DG1-02
Middle
MW-37S
474
DG1-03
Middle
12 to 22
MW-37S
474
DG1-04
Middle
MW-37S
474
DG1-05
Middle
12 to 24
MW-37S
474
DG1-06
Middle / Lower
12 to 22 /
25 to 41
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-07
Middle / Lower
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-08
Middle / Lower
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-09
Middle / Lower
MW-37S / MW-47D
474 / 99.7
Separate injection locations for Middle and Lower Aquifer
DG1-10
Middle
12 to 22
MW-37S
474
DG1-11
Middle
MW-37S
474
DG1-12
Middle
MW-37S
474
DG1-13
Middle
MW-37S
474
DG1-14
Middle
MW-37S
474
Downgradient
Area 2
)
DG2-01
Lower
35 to 45
MW-74D
86.6
DG2-02
Lower
MW-74D
86.6
DG2-03
Lower
MW-74D
86.6
DG2-04
Lower
MW-74D
86.6
Downgradient
Area 3
(DG3)
DG3-01
Lower
38 to 50
MW-41DDR
377
DG3-02
Lower
MW-41DDR
377
DG3-03
Lower
MW-41DDR
377
DG3-04
Lower
MW-41DDR
377
DG3-05
Lower
MW-41DDR
377
DG3-06
Lower
MW-41DDR
377
DG3-07
Lower
MW-41DDR
377
DG3-08
Lower
MW-41DDR
377
DG3-09
Lower
MW-70D
172
DG3-10
Lower
40 to 50
MW-70D
172
DG3-11
Lower
MW-70D
172
DG3-12
Lower
MW-70D
172
Notes:
1. ft BLS indicates feet below land surface.
2. DPT indicates direct push technology.
3. PCE indicates tetrachloroethene.
4. µg/L indicates micrograms per liter.
5. ✓ indicates zero-valent iron (ZVI) is included at the location. No fill indicates ZVI will not be included.
6. Primary PCE Concentration(s) provides the most recent PCE sampling result (as of February 2021) for the monitoring well(s) used for design.
7. All locations will be confirmed in the field, based on nearby monitoring wells.
2021 Bioremediation Interim Measures Workplan Page 1 of 1

Table 4. Injection Location Volumes
Allegion Rocky Mount
Rocky Mount, North Carolina
Geasyntec°
consultants
IP : ("un%Pl[nnb nl NC. PC
ABC+* Amendment Injection Locations (includes ZVI)
Per 2-ft Injection Interval
Per Injection Location
Target
Aquifer
Injection
Area
Injection Locations
Treatment
Interval
(ft BLS)
Injection
Interval
(ft BLS)
Target
ROI
(ft)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
High Concentration Area - 0.3 lb of Carbon Amendment per ft3 of Treatment Volume
Middle
Aquifer
HC2
HC2-01, HC2-02,
HC2-03, HC2-04,
HC2-05, HC2-06,
HC2-07, HC2-08,
HC2-09, HC2-10,
HC2-11
16 to 32
16
to
18
14
283
109
0.65
2.264
872
5.20
18
to
20
14
283
109
0.65
20
to
22
14
283
109
0.65
22
to
24
14
283
109
0.65
24
to
26
14
283
109
0.65
26
to
28
14
283
109
0.65
28
to
30
14
283
109
0.65
30
to
32
14
283
109
0.65
HC3
HC3-01, HC3-02,
HC3-03, HC3-04
16 to 30
16
to
18
14
284
108
0.65
1.988
756
4.55
18
to
20
14
284
108
0.65
20
to
22
14
284
108
0.65
22
to
24
14
284
108
0.65
24
to
26
14
284
108
0.65
26
to
28
14
284
108
0.65
28
to
30
14
284
108
0.65
Lower
Aquifer
HC3
HC3-03, HC3-04,
HC3-07
34 to 50
34
to
36
14
288
105
0.65
2.304
840
5.20
36
to
38
14
288
105
0.65
38
to
40
14
288
105
0.65
40
to
42
14
288
105
0.65
42
to
44
14
288
105
0.65
44
to
46
14
288
105
0.65
46
to
48
14
288
105
0.65
48
to
50
14
288
105
0.65
ABC® Amendment Injection Location (no ZVI) OM
Per 2-ft Injection Interval
Per Injection Location
Target
Aquifer
Injection
Area
Injection Locations
Treatment
Interval
(ft BLS)
Injection
Interval
(ft BLS)
Target
ROI
(ft)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
High Concentration 0.3 lb of Carbon Amendment per fe of Treatment Volume
Middle
Aquifer
HCl
HC1-01,HC1-02,
HC1-03,HC1-04
188032
18
to
20
14
379
83
0.65
2,653
581
4.55
20
to
22
14
379
83
0.65
22
to
24
14
379
83
0.65
24
to
26
14
379
83
0.65
26
to
28
14
379
83
0.65
28
to
30
14
379
83
0.65
30
to
32
14
379
83
0.65
HC1
HC1-05,HC1-06
14to36
14
to
16
14
382
79
0.65
4.202
869
7.15
16
to
18
14
382
79
0.65
18
to
20
14
382
79
0.65
20
to
22
14
382
79
0.65
22
to
24
14
382
79
0.65
24
to
26
14
382
79
0.65
26
to
28
14
382
79
0.65
28
to
30
14
382
79
0.65
30
to
32
14
382
79
0.65
32
to
34
14
382
79
0.65
34
to
36
14
382
79
0.65
HC2
HC2-12, HC2-13,
HC2-14, HC2-15,
HC2-25, HC2-26,
HC2-27, HC2-28,
HC2-29, HC2-30
19 to 31
19
to
21
14
377
84
0.65
2.262
504
3.90
21
to
23
14
377
84
0.65
23
to
25
14
377
84
0.65
25
to
27
14
377
84
0.65
27
to
29
14
377
84
0.65
29
to
31
14
377
84
0.65
HC2
HC2-16, HC2-17,
HC2-18, HC2-19
22 to 36
22
to
24
14
379
83
0.65
2,653
581
4.55
24
to
26
14
379
83
0.65
26
to
28
14
379
83
0.65
28
to
30
14
379
83
0.65
30
to
32
14
379
83
0.65
32
to
34
14
379
83
0.65
34
to
36
14
379
83
0.65
HC2
HC2-20, HC2-21,
HC2-22, HC2-23,
HC-24
21 to 33
21
to
23
14
380
81
0.65
2,280
486
3.90
23
to
25
14
380
81
0.65
25
to
27
14
380
81
0.65
27
to
29
14
380
81
0.65
29
to
31
14
380
81
0.65
31
to
33
14
380
81
0.65
HC3
HC3-05, HC3-06,
HC3-07, HC3-08
HC3-09, HC3-10
18 to 30
18
to
20
14
378
83
0.65
2,268
498
3.90
20
to
22
14
378
83
0.65
22
to
24
14
378
83
0.65
24
to
26
14
378
83
0.65
26
to
28
14
378
83
0.65
28
to
30
14
378
83
0.65
HC3
HC3-11, HC3-12,
HC3-13, HC3-14,
HC3-15
17 to 29
17
to
19
14
380
81
0.65
2,280
486
3.90
19
to
21
14
380
81
0.65
21
to
23
14
380
81
0.65
23
to
25
14
380
81
0.65
25
to
27
14
380
81
0.65
27
to
29
14
380
81
0.65
2021 Bioremediation Interim Measures Workplan Page 1 of 2

Table 4. Injection Location Volumes
Allegion Rocky Mount
Rocky Mount, North Carolina
Geasyntec°
consultants
1,
Ic+� ConsRltnnb nl NC. PC
ABC® Amendment Injection Location (no ZVI)
Per 2-ft Injection Interval
Per Injection Location
Target
Aquifer
Injection
Area
Injection Locations
Treatment
Interval
(ft BLS)
Injection
Interval
(ft BLS)
Target
ROI
(ft)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
Diluted
Carbon
Amendment
Volume
(gal)
Anaerobic
Chase Water
Volume
(gal)
KB-1
Volume
(liter)
High Concentration 0.3 Ib of Carbon Amendment per ftS of Treatment Volume
Lower
Aquifer
HC1
HC1-01,HC1-O5,
HC1-06
40 to 50
40
to
42
14
387
74
0.65
1,935
370
3.25
42
to
44
14
387
74
0.65
44
to
46
14
387
74
0.65
46
to
48
14
387
74
0.65
48
to
50
14
387
74
0.65
HCl
HC1-02,HC1-03,
HC1-04
38to50
38
to
40
14
378
83
0.65
2,268
498
3.90
40
to
42
14
378
83
0.65
42
to
44
14
378
83
0.65
44
to
46
14
378
83
0.65
46
to
48
14
378
83
0.65
48
to
50
14
378
83
0.65
HC3
HC3-01, HC3-02,40
HC3-08 HC3-09,
HC3-10
34 to 50
34
to
36
14
380
81
0.65
3.040
648
5.20
36
to
38
14
380
81
0.65
38
to
40
14
380
81
0.65
to
42
14
380
81
0.65
42
to
44
14
380
81
0.65
44
to
46
14
380
81
0.65
46
to
48
14
380
81
0.65
48
to
50
14
380
81
0.65
HC4
HC4-01, HC4-02,
HC4-03
26 to 46
26
to
28
14
380
81
0.65
3,800
810
6.50
28
to
30
14
380
81
0.65
30
to
32
14
380
81
0.65
32
to
34
14
380
81
0.65
34
to
36
14
380
81
0.65
36
to
38
14
380
81
0.65
38
to
40
14
380
81
0.65
40
to
42
14
380
81
0.65
42
to
44
14
380
81
0.65
44
to
46
14
380
81
0.65
Downgradient Area - 0.30 Ib of Carbon Amendment per ft3 of Treatment Volume
Middle
Aquifer
DG1
DG1-05
12 to 24
12
to
14
14
467
110
0.80
2.802
660
4.80
14
to
16
14
467
110
0.80
16
to
18
14
467
110
0.80
18
to
20
14
467
110
0.80
20
to
22
14
467
110
0.80
22
to
24
14
467
110
0.80
DG1
DG1-01, DG1-02,
DG1-03, DG1-04,
DG1-06, DG1-07,
DG1-08, DG1-09,
DG1-10, DG1-11,
DG1-12, DG1-13,
DG1-14
12 to 22
12
to
14
14
465
112
0.80
2.325
560
4.00
14
to
16
14
465
112
0.80
16
to
18
14
465
112
0.80
18
to
20
14
465
112
0.80
20
to
22
14
465
112
0.80
Lower
Aquifer
DG1
DG1-06, DG1-07,
DG1-08, DG1-09
25 to 41
25
to
27
14
475
101
0.80
3.800
808
6.40
27
to
29
14
475
101
0.80
29
to
31
14
475
101
0.80
31
to
33
14
475
101
0.80
33
to
35
14
475
101
0.80
35
to
37
14
475
101
0.80
37
to
39
14
475
101
0.80
39
to
41
14
475
101
0.80
DG235
DG2-01, DG2-02,
DG2-03, DG2-04
to 45
35
to
37
14
470
106
0.80
2,350
530
4.00
37
to
39
14
470
106
0.80
39
to
41
14
470
106
0.80
41
to
43
14
470
106
0.80
43
to
45
14
470
106
0.80
DG3
DG3-01, DG3-02,
DG3-03, DG3-04,
DG3-05, DG3-06,
DG3-07, DG3-08,
DG3-09
38 to 50
38
to
40
14
474
102
0.80
'.844
612
4.80
40
to
42
14
474
102
0.80
42
to
44
14
474
102
0.80
44
to
46
14
474
102
0.80
46
to
48
14
474
102
0.80
48
to
50
14
474
102
0.80
DG3
DG3-10, DG3-11,
DG3-12
40 to 50
40
to
42
14
467
110
0.80
2,335
550
4.00
42
to
44
14
467
110
0.80
44
to
46
14
467
110
0.80
46
to
48
14
467
110
0.80
48
to
50
14
467
110
0.80
Notes:
1. ft BLS indicates feet below land surface.
2. gal indicates gallons.
3. ZVI indicates zero-valent iron.
4. Ib indicates pound.
5. ft' indicates cubic foot.
6. KB-1 Volume refs to the volume ofbioaugmentation culture required. See Work Plan for details on the selection of KB-1 versus KB-1 Plus by location.
2021 Bioremediation Interim Measures Workplan Page 2 of 2